| 1 | Association of Phosphodiesterase-5 Inhibitor Treatment With Improved Survival in Pulmonary Hypertension Associated With COPD in the Pulmonary Vascular Research Institute GoDeep Meta-RegistryChest, 2025, 167, 224-240 | 1.1 | 10 | Citations (PDF) |
| 2 | Case Series Evaluating the Relationship of SGLT2 Inhibition to Pulmonary Artery Pressure and Non-Invasive Cardiopulmonary Parameters in HFpEF/HFmrEF Patients—A Pilot Study | 3.1 | 0 | Citations (PDF) |
| 3 | Alveolar macrophage-expressed Plet1 is a driver of lung epithelial repair after viral pneumonia | 13.9 | 36 | Citations (PDF) |
| 4 | miR-147b mediated suppression of DUSP8 promotes lung cancer progression | 6.7 | 11 | Citations (PDF) |
| 5 | Right ventricular pressure-strain relationship-derived myocardial work reflects contractility: Validation with invasive pressure-volume analysis | 1.2 | 16 | Citations (PDF) |
| 6 | GLI1+ Cells Contribute to Vascular Remodeling in Pulmonary Hypertension | 12.6 | 13 | Citations (PDF) |
| 7 | Impact of different tissue dissociation protocols on endothelial cell recovery from developing mouse lungs | 2.3 | 1 | Citations (PDF) |
| 8 | Air travel in patients suffering from pulmonary hypertension—A prospective, multicentre study | 2.1 | 3 | Citations (PDF) |
| 9 | Clinical trial design, end-points, and emerging therapies in pulmonary arterial hypertension | 8.7 | 17 | Citations (PDF) |
| 10 | Postoperative Fluid Accumulation is Associated With Underestimation of AKI Severity in Lung Transplant Recipients | 1.7 | 1 | Citations (PDF) |
| 11 | Imaging the right atrium in pulmonary hypertension: A systematic review and meta-analysis | 1.2 | 28 | Citations (PDF) |
| 12 | iNOS Deletion in Alveolar Epithelium Cannot Reverse the Elastase-Induced Emphysema in Mice | 4.8 | 2 | Citations (PDF) |
| 13 | Decreased plasma levels of the brain-derived neurotrophic factor correlate with right heart congestion in pulmonary arterial hypertension | 2.6 | 4 | Citations (PDF) |
| 14 | Targeting Wnt-ß-Catenin-FOSL Signaling Ameliorates Right Ventricular Remodeling | 12.6 | 39 | Citations (PDF) |
| 15 | The HDAC2-SP1 Axis Orchestrates Protumor Macrophage Polarization | 0.6 | 45 | Citations (PDF) |
| 16 | Nicotine promotes e-cigarette vapour-induced lung inflammation and structural alterations | 8.7 | 32 | Citations (PDF) |
| 17 | Clinical and functional relevance of right ventricular contraction patterns in pulmonary hypertension | 1.2 | 15 | Citations (PDF) |
| 18 | Echocardiographic evaluation of right ventricular diastolic function in pulmonary hypertension | 2.6 | 14 | Citations (PDF) |
| 19 | <scp>ADPGK‐AS1</scp> long noncoding <scp>RNA</scp> switches macrophage metabolic and phenotypic state to promote lung cancer growth | 7.5 | 25 | Citations (PDF) |
| 20 | Transcriptional profiling unveils molecular subgroups of adaptive and maladaptive right ventricular remodeling in pulmonary hypertension | 9.1 | 41 | Citations (PDF) |
| 21 | Changes in Doppler‐Derived Kidney Venous Flow and Adverse Cardiorenal Outcomes in Patients With Heart Failure | 4.3 | 15 | Citations (PDF) |
| 22 | Fibroblast growth factor 10 reverses cigarette smoke- and elastase-induced emphysema and pulmonary hypertension in mice | 8.7 | 19 | Citations (PDF) |
| 23 | Genetic deletion of p66shc and/or cyclophilin D results in decreased pulmonary vascular tone | 5.5 | 14 | Citations (PDF) |
| 24 | A novel non-invasive and echocardiography-derived method for quantification of right ventricular pressure–volume loops | 1.4 | 36 | Citations (PDF) |
| 25 | Macrophage-derived IL-6 trans-signalling as a novel target in the pathogenesis of bronchopulmonary dysplasia | 8.7 | 104 | Citations (PDF) |
| 26 | Myeloid-cell-specific deletion of inducible nitric oxide synthase protects against smoke-induced pulmonary hypertension in mice | 8.7 | 25 | Citations (PDF) |
| 27 | Risk assessment in pulmonary hypertension based on routinely measured laboratory parameters | 1.2 | 28 | Citations (PDF) |
| 28 | Effects of BPA on right ventricular mechanical dysfunction in patients with inoperable CTEPH – A cardiac magnetic resonance study | 2.9 | 15 | Citations (PDF) |
| 29 | Differential LysoTracker Uptake Defines Two Populations of Distal Epithelial Cells in Idiopathic Pulmonary Fibrosis | 4.8 | 11 | Citations (PDF) |
| 30 | Epigenetic Mechanisms in Parenchymal Lung Diseases: Bystanders or Therapeutic Targets? | 4.5 | 29 | Citations (PDF) |
| 31 | Picturing of the Lung Tumor Cellular Composition by Multispectral Flow Cytometry | 5.1 | 9 | Citations (PDF) |
| 32 | Targeting peptidyl-prolyl isomerase 1 in experimental pulmonary arterial hypertension | 8.7 | 7 | Citations (PDF) |
| 33 | An essential function for autocrine hedgehog signaling in epithelial proliferation and differentiation in the trachea | 3.0 | 14 | Citations (PDF) |
| 34 | Noncanonical HIPPO/MST Signaling via BUB3 and FOXO Drives Pulmonary Vascular Cell Growth and Survival | 12.6 | 46 | Citations (PDF) |
| 35 | Relevance of Cor Pulmonale in COPD With and Without Pulmonary Hypertension: A Retrospective Cohort Study | 2.6 | 23 | Citations (PDF) |
| 36 | Immunogenicity and reactogenicity of homologous mRNA-based and vector-based SARS-CoV-2 vaccine regimens in patients receiving maintenance dialysis | 2.7 | 12 | Citations (PDF) |
| 37 | Unmasking right ventricular-arterial uncoupling during fluid challenge in pulmonary hypertension | 1.2 | 18 | Citations (PDF) |
| 38 | SPARC, a Novel Regulator of Vascular Cell Function in Pulmonary Hypertension | 25.3 | 45 | Citations (PDF) |
| 39 | Effects of preoperative high-oral protein loading on short- and long-term renal outcomes following cardiac surgery: a cohort study | 6.7 | 18 | Citations (PDF) |
| 40 | Utility and Drawbacks of Chimeric Antigen Receptor T Cell (CAR-T) Therapy in Lung Cancer | 5.1 | 34 | Citations (PDF) |
| 41 | Epigenetic reactivation of transcriptional programs orchestrating fetal lung development in human pulmonary hypertension | 13.4 | 58 | Citations (PDF) |
| 42 | Transcriptional Profiling of Insulin-like Growth Factor Signaling Components in Embryonic Lung Development and Idiopathic Pulmonary Fibrosis | 4.8 | 10 | Citations (PDF) |
| 43 | Mitochondrial Respiration in Peripheral Blood Mononuclear Cells Negatively Correlates with Disease Severity in Pulmonary Arterial Hypertension | 2.6 | 13 | Citations (PDF) |
| 44 | Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life | 13.9 | 27 | Citations (PDF) |
| 45 | Pulmonary Vascular Research Institute GoDeep: A meta‐registry merging deep phenotyping datafrom international PH reference centers | 2.1 | 17 | Citations (PDF) |
| 46 | Fibrocytes boost tumor-supportive phenotypic switches in the lung cancer niche via the endothelin system | 13.9 | 17 | Citations (PDF) |
| 47 | Bayesian Inference Associates Rare
<i>KDR</i>
Variants With Specific Phenotypes in Pulmonary Arterial Hypertension | 3.4 | 43 | Citations (PDF) |
| 48 | Amelioration of elastase‐induced lung emphysema and reversal of pulmonary hypertension by pharmacological iNOS inhibition in mice | 6.4 | 30 | Citations (PDF) |
| 49 | Targeting Jak–Stat Signaling in Experimental Pulmonary Hypertension | 4.3 | 64 | Citations (PDF) |
| 50 | CILP1 as a biomarker for right ventricular maladaptation in pulmonary hypertension | 8.7 | 25 | Citations (PDF) |
| 51 | Congestive nephropathy: a neglected entity? Proposal for diagnostic criteria and future perspectives | 3.3 | 144 | Citations (PDF) |
| 52 | Immunoglobulin deficiency as an indicator of disease severity in patients with COVID-19 | 3.4 | 23 | Citations (PDF) |
| 53 | Severe organising pneumonia following COVID-19 | 5.8 | 82 | Citations (PDF) |
| 54 | The H2S-generating enzyme 3-mercaptopyruvate sulfurtransferase regulates pulmonary vascular smooth muscle cell migration and proliferation but does not impact normal or aberrant lung development | 3.1 | 7 | Citations (PDF) |
| 55 | Right heart failure in pulmonary hypertension: Diagnosis and new perspectives on vascular and direct right ventricular treatment | 6.4 | 59 | Citations (PDF) |
| 56 | Targeting histone acetylation in pulmonary hypertension and right ventricular hypertrophy | 6.4 | 100 | Citations (PDF) |
| 57 | Genetic Delivery and Gene Therapy in Pulmonary Hypertension | 4.5 | 32 | Citations (PDF) |
| 58 | The Lung Vasculature: A Driver or Passenger in Lung Branching Morphogenesis? | 3.7 | 16 | Citations (PDF) |
| 59 | Evaluation of Regional Pulmonary Ventilation in Spontaneously Breathing Patients with Idiopathic Pulmonary Fibrosis (IPF) Employing Electrical Impedance Tomography (EIT): A Pilot Study from the European IPF Registry (eurIPFreg) | 2.6 | 9 | Citations (PDF) |
| 60 | Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension | 4.5 | 7 | Citations (PDF) |
| 61 | Impact of the new definition for pulmonary hypertension in patients with lung disease: an analysis of the United Network for Organ Sharing database | 2.1 | 33 | Citations (PDF) |
| 62 | Utilising biomarkers to predict right heart maladaptive phenotype: a step toward precision medicine | 8.7 | 1 | Citations (PDF) |
| 63 | Validity of echocardiographic tricuspid regurgitation gradient to screen for new definition of pulmonary hypertension | 8.5 | 36 | Citations (PDF) |
| 64 | Right ventricular pressure-volume loop shape and systolic pressure change in pulmonary hypertension | 3.4 | 38 | Citations (PDF) |
| 65 | The effect of long-term doxycycline treatment in a mouse model of cigarette smoke-induced emphysema and pulmonary hypertension | 3.4 | 12 | Citations (PDF) |
| 66 | Protocol for the generation of murine bronchiolospheres | 1.2 | 7 | Citations (PDF) |
| 67 | Exercise hemodynamics in heart failure patients with preserved and mid-range ejection fraction: key role of the right heart | 3.2 | 8 | Citations (PDF) |
| 68 | Hypercapnia Induces Inositol-Requiring Enzyme 1α–Driven Endoplasmic Reticulum–associated Degradation of the Na,K-ATPase β-Subunit | 4.3 | 13 | Citations (PDF) |
| 69 | TRAF2 Is a Novel Ubiquitin E3 Ligase for the Na,K-ATPase β-Subunit That Drives Alveolar Epithelial Dysfunction in Hypercapnia | 3.7 | 5 | Citations (PDF) |
| 70 | Exposomes to Exosomes: Exosomes as Tools to Study Epigenetic Adaptive Mechanisms in High-Altitude Humans | 3.1 | 12 | Citations (PDF) |
| 71 | Deficiency of Axl aggravates pulmonary arterial hypertension via BMPR2 | 4.5 | 14 | Citations (PDF) |
| 72 | Osteopontin and Galectin-3 As Biomarkers of Maladaptive Right Ventricular Remodeling In Pulmonary Hypertension | 1.7 | 7 | Citations (PDF) |
| 73 | Evidence for Multiple Origins of De Novo Formed Vascular Smooth Muscle Cells in Pulmonary Hypertension: Challenging the Dominant Model of Pre-Existing Smooth Muscle Expansion | 3.1 | 1 | Citations (PDF) |
| 74 | Renal markers for monitoring acute kidney injury transition to chronic kidney disease after COVID-19 | 0.8 | 6 | Citations (PDF) |
| 75 | Hidden Treasures: Macrophage Long Non-Coding RNAs in Lung Cancer Progression | 4.0 | 15 | Citations (PDF) |
| 76 | Impairment of hypoxic pulmonary vasoconstriction in acute respiratory distress syndrome | 8.8 | 31 | Citations (PDF) |
| 77 | Adenylate Kinase 4—A Key Regulator of Proliferation and Metabolic Shift in Human Pulmonary Arterial Smooth Muscle Cells via Akt and HIF-1α Signaling Pathways | 4.5 | 29 | Citations (PDF) |
| 78 | Interferon Regulatory Factor 9 Promotes Lung Cancer Progression via Regulation of Versican | 4.0 | 18 | Citations (PDF) |
| 79 | Clinical Relevance of Right Atrial Functional Response to Treatment in Pulmonary Arterial Hypertension | 2.6 | 17 | Citations (PDF) |
| 80 | Altered proteasome function in right ventricular hypertrophy | 5.5 | 12 | Citations (PDF) |
| 81 | Characterization of <i>GDF2</i> Mutations and Levels of BMP9 and BMP10 in Pulmonary Arterial Hypertension | 12.2 | 112 | Citations (PDF) |
| 82 | Epithelial cell plasticity defines heterogeneity in lung cancer | 3.6 | 37 | Citations (PDF) |
| 83 | Association of right atrial conduit phase with right ventricular lusitropic function in pulmonary hypertension | 1.3 | 25 | Citations (PDF) |
| 84 | Right ventricular function correlates of right atrial strain in pulmonary hypertension: a combined cardiac magnetic resonance and conductance catheter study | 3.8 | 62 | Citations (PDF) |
| 85 | Metabolism in tumour-associated macrophages: a <i>quid pro quo</i> with the tumour microenvironment | 8.8 | 37 | Citations (PDF) |
| 86 | Advanced risk stratification of intermediate risk group in pulmonary arterial hypertension | 2.1 | 22 | Citations (PDF) |
| 87 | IRAG1 Deficient Mice Develop PKG1β Dependent Pulmonary Hypertension | 4.8 | 9 | Citations (PDF) |
| 88 | Extracorporeal Carbon Dioxide Removal Using a Renal Replacement Therapy Platform to Enhance Lung-Protective Ventilation in Hypercapnic Patients With Coronavirus Disease 2019-Associated Acute Respiratory Distress Syndrome | 2.6 | 17 | Citations (PDF) |
| 89 | Minoxidil Cannot Be Used To Target Lysyl Hydroxylases during Postnatal Mouse Lung Development: A Cautionary Note | 3.1 | 2 | Citations (PDF) |
| 90 | Effects of macitentan and tadalafil monotherapy or their combination on the right ventricle and plasma metabolites in pulmonary hypertensive rats | 2.1 | 14 | Citations (PDF) |
| 91 | Assessing the Effectiveness of Pirfenidone in Idiopathic Pulmonary Fibrosis: Long-Term, Real-World Data from European IPF Registry (eurIPFreg) | 2.6 | 15 | Citations (PDF) |
| 92 | Clinical and Functional Characteristics of Patients with Unclassifiable Interstitial Lung Disease (uILD): Long-Term Follow-Up Data from European IPF Registry (eurIPFreg) | 2.6 | 22 | Citations (PDF) |
| 93 | Impact of litter size on survival, growth and lung alveolarization of newborn mouse pups | 1.5 | 3 | Citations (PDF) |
| 94 | Spatial Density and Distribution of Tumor-Associated Macrophages Predict Survival in Non–Small Cell Lung Carcinoma | 0.6 | 184 | Citations (PDF) |
| 95 | Impact of SARS‐CoV‐2 pandemic on pulmonary hypertension out‐patient clinics in Germany: a multi‐centre study | 2.1 | 15 | Citations (PDF) |
| 96 | Fibroblast Growth Factor—14 Acts as Tumor Suppressor in Lung Adenocarcinomas | 4.8 | 20 | Citations (PDF) |
| 97 | Commercially available transfection reagents and negative control siRNA are not inert | 2.4 | 4 | Citations (PDF) |
| 98 | Isoform-specific characterization of class I histone deacetylases and their therapeutic modulation in pulmonary hypertension | 3.5 | 36 | Citations (PDF) |
| 99 | Risk assessment in severe pulmonary hypertension due to interstitial lung disease | 1.2 | 22 | Citations (PDF) |
| 100 | Metastasis-Associated Protein 2 Represses NF-κB to Reduce Lung Tumor Growth and Inflammation | 0.6 | 16 | Citations (PDF) |
| 101 | Decreased Thymic Output Contributes to Immune Defects in Septic Patients | 2.6 | 11 | Citations (PDF) |
| 102 | Genetic Deficiency and Pharmacological Stabilization of Mast Cells Ameliorate Pressure Overload-Induced Maladaptive Right Ventricular Remodeling in Mice | 4.5 | 8 | Citations (PDF) |
| 103 | Effect of p53 activation on experimental right ventricular hypertrophy | 2.4 | 7 | Citations (PDF) |
| 104 | NADPH oxidase subunit NOXO1 is a target for emphysema treatment in COPD | 18.5 | 32 | Citations (PDF) |
| 105 | Cytochrome P450 epoxygenase‐derived 5,6‐epoxyeicosatrienoic acid relaxes pulmonary arteries in normoxia but promotes sustained pulmonary vasoconstriction in hypoxia | 3.7 | 13 | Citations (PDF) |
| 106 | Reprogramming of tumor-associated macrophages by targeting β-catenin/FOSL2/ARID5A signaling: A potential treatment of lung cancer | 11.2 | 173 | Citations (PDF) |
| 107 | Immunomodulation by an Omega-6 Fatty Acid Reduced Mixed Lipid Emulsion in Murine Acute Respiratory Distress Syndrome | 2.6 | 5 | Citations (PDF) |
| 108 | Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ | 12.2 | 69 | Citations (PDF) |
| 109 | The Multi-Modal Effect of the Anti-fibrotic Drug Pirfenidone on NSCLC | 2.7 | 36 | Citations (PDF) |
| 110 | Hypercapnia Impairs Na,K-ATPase Function by Inducing Endoplasmic Reticulum Retention of the β-Subunit of the Enzyme in Alveolar Epithelial Cells | 4.5 | 18 | Citations (PDF) |
| 111 | Implication of in vivo circulating fibrocytes ablation in experimental pulmonary hypertension murine model | 6.4 | 4 | Citations (PDF) |
| 112 | Right ventricular dyssynchrony: from load-independent right ventricular function to wall stress in severe pulmonary arterial hypertension | 2.1 | 9 | Citations (PDF) |
| 113 | SPARCL1 as a biomarker of maladaptive right ventricular remodelling in pulmonary hypertension | 1.8 | 19 | Citations (PDF) |
| 114 | Bypassing mitochondrial complex III using alternative oxidase inhibits acute pulmonary oxygen sensing | 11.2 | 59 | Citations (PDF) |
| 115 | Macrophage and Tumor Cell Cross-Talk Is Fundamental for Lung Tumor Progression: We Need to Talk | 2.7 | 111 | Citations (PDF) |
| 116 | Microenvironmental Th9 and Th17 lymphocytes induce metastatic spreading in lung cancer | 9.0 | 153 | Citations (PDF) |
| 117 | Hypoxia-inducible factor signaling in pulmonary hypertension | 9.0 | 198 | Citations (PDF) |
| 118 | SCRINSHOT enables spatial mapping of cell states in tissue sections with single-cell resolution | 4.9 | 80 | Citations (PDF) |
| 119 | Multilineage murine stem cells generate complex organoids to model distal lung development and disease | 7.5 | 72 | Citations (PDF) |
| 120 | Cancer and pulmonary hypertension: Learning lessons and real-life interplay | 0.3 | 5 | Citations (PDF) |
| 121 | Persistent decrease of renal functional reserve in patients after cardiac surgery-associated acute kidney injury despite clinical recovery | 0.8 | 82 | Citations (PDF) |
| 122 | Susceptibility of microtubule‐associated protein 1 light chain 3β (MAP1LC3B/LC3B) knockout mice to lung injury and fibrosis | 0.7 | 19 | Citations (PDF) |
| 123 | Clinical characteristics of patients with familial idiopathic pulmonary fibrosis (f-IPF) | 2.6 | 45 | Citations (PDF) |
| 124 | Indefinite cytomegalovirus prophylaxis with valganciclovir after lung transplantation | 2.2 | 6 | Citations (PDF) |
| 125 | Metformin induces lipogenic differentiation in myofibroblasts to reverse lung fibrosis | 13.9 | 257 | Citations (PDF) |
| 126 | Exploring the Ability of Electronic Nose Technology to Recognize Interstitial Lung Diseases (ILD) by Non-Invasive Breath Screening of Exhaled Volatile Compounds (VOC): A Pilot Study from the European IPF Registry (eurIPFreg) and Biobank | 2.6 | 28 | Citations (PDF) |
| 127 | Acute response to rapid iloprost inhalation using the Breelib™ nebulizer in pulmonary arterial hypertension: the Breelib™ acute study | 2.1 | 4 | Citations (PDF) |
| 128 | Doppler‐Derived Renal Venous Stasis Index in the Prognosis of Right Heart Failure | 4.3 | 108 | Citations (PDF) |
| 129 | Validation of the Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio for the Assessment of Right Ventricular-Arterial Coupling in Severe Pulmonary Hypertension | 3.3 | 436 | Citations (PDF) |
| 130 | Impaired right ventricular lusitropy is associated with ventilatory inefficiency in pulmonary arterial hypertension | 8.7 | 27 | Citations (PDF) |
| 131 | Resolvin E1 Improves Mitochondrial Function in Human Alveolar Epithelial Cells during Severe Inflammation | 1.4 | 19 | Citations (PDF) |
| 132 | Inactivation of nuclear histone deacetylases by EP300 disrupts the MiCEE complex in idiopathic pulmonary fibrosis | 13.9 | 73 | Citations (PDF) |
| 133 | Targeting cyclin-dependent kinases for the treatment of pulmonary arterial hypertension | 13.9 | 87 | Citations (PDF) |
| 134 | A RASSF1A-HIF1α loop drives Warburg effect in cancer and pulmonary hypertension | 13.9 | 108 | Citations (PDF) |
| 135 | A simple echocardiographic estimate of right ventricular-arterial coupling to assess severity and outcome in pulmonary hypertension on chronic lung disease | 8.7 | 48 | Citations (PDF) |
| 136 | Exhalative Breath Markers Do Not Offer for Diagnosis of Interstitial Lung Diseases: Data from the European IPF Registry (eurIPFreg) and Biobank | 2.6 | 15 | Citations (PDF) |
| 137 | Lamin B1 loss promotes lung cancer development and metastasis by epigenetic derepression of RET | 8.0 | 71 | Citations (PDF) |
| 138 | Estimation of absolute number of alveolar epithelial type 2 cells in mouse lungs: a comparison between stereology and flow cytometry | 1.7 | 15 | Citations (PDF) |
| 139 | Regulation and role of the ER stress transcription factor CHOP in alveolar epithelial type-II cells | 3.8 | 44 | Citations (PDF) |
| 140 | Psychometric properties and minimal important differences of SF-36 in Idiopathic Pulmonary Fibrosis | 4.5 | 44 | Citations (PDF) |
| 141 | Mouse genetic background impacts susceptibility to hyperoxia‐driven perturbations to lung maturation | 2.2 | 22 | Citations (PDF) |
| 142 | miR‐574‐5p as RNA decoy for CUGBP1 stimulates human lung tumor growth by mPGES‐1 induction | 0.7 | 37 | Citations (PDF) |
| 143 | Protection against pressure overload-induced right heart failure by uncoupling protein 2 silencing | 5.5 | 24 | Citations (PDF) |
| 144 | Lung CT Densitometry in Idiopathic Pulmonary Fibrosis for the Prediction of Natural Course, Severity, and MortalityChest, 2019, 155, 972-981 | 1.1 | 39 | Citations (PDF) |
| 145 | Cardiac Magnetic Resonance Imaging-Based Right Ventricular Strain Analysis for Assessment of Coupling and Diastolic Function in Pulmonary Hypertension | 6.9 | 105 | Citations (PDF) |
| 146 | Targeting miR‐34a/
<i>Pdgfra</i>
interactions partially corrects alveologenesis in experimental bronchopulmonary dysplasia | 7.3 | 44 | Citations (PDF) |
| 147 | Riociguat for treatment of pulmonary hypertension in COPD: a translational study | 8.7 | 34 | Citations (PDF) |
| 148 | Genetic determinants of risk in pulmonary arterial hypertension: international genome-wide association studies and meta-analysis | 24.1 | 186 | Citations (PDF) |
| 149 | Evidence for the Fucoidan/P-Selectin Axis as a Therapeutic Target in Hypoxia-induced Pulmonary Hypertension | 12.2 | 48 | Citations (PDF) |
| 150 | Multibeat Right Ventricular–Arterial Coupling during a Positive Acute Vasoreactivity Test | 12.2 | 9 | Citations (PDF) |
| 151 | Reserve of Right Ventricular-Arterial Coupling in the Setting of Chronic Overload | 5.5 | 230 | Citations (PDF) |
| 152 | Control Interventions Can Impact Alveolarization and the Transcriptome in Developing Mouse Lungs | 1.8 | 6 | Citations (PDF) |
| 153 | Pulmonary hypertension in chronic lung disease and hypoxia | 8.7 | 625 | Citations (PDF) |
| 154 | Nitric Oxide Synthase 2 Induction Promotes Right Ventricular Fibrosis | 4.3 | 21 | Citations (PDF) |
| 155 | Process Evaluation of a Medical Student–Delivered Smoking Prevention Program for Secondary Schools: Protocol for the Education Against Tobacco Cluster Randomized Trial | 1.3 | 4 | Citations (PDF) |
| 156 | Alterations in Doppler-derived renal venous stasis index during recompensation of right heart failure and fluid overload in a patient with pulmonary hypertension | 1.2 | 7 | Citations (PDF) |
| 157 | Identification of rare sequence variation underlying heritable pulmonary arterial hypertension | 13.9 | 346 | Citations (PDF) |
| 158 | Preoperative Renal Functional Reserve Predicts Risk of Acute Kidney Injury After Cardiac Operation | 2.4 | 112 | Citations (PDF) |
| 159 | Impact of the mitochondria-targeted antioxidant MitoQ on hypoxia-induced pulmonary hypertension | 8.7 | 83 | Citations (PDF) |
| 160 | Stereological analysis of individual lung lobes during normal and aberrant mouse lung alveolarisation | 1.8 | 14 | Citations (PDF) |
| 161 | Eplerenone attenuates pathological pulmonary vascular rather than right ventricular remodeling in pulmonary arterial hypertension | 2.6 | 56 | Citations (PDF) |
| 162 | Transmission of microRNA antimiRs to mouse offspring via the maternal–placental–fetal unit | 3.8 | 5 | Citations (PDF) |
| 163 | ASK1 Inhibition Halts Disease Progression in Preclinical Models of Pulmonary Arterial Hypertension | 12.2 | 93 | Citations (PDF) |
| 164 | FoxO3 an important player in fibrogenesis and therapeutic target for idiopathic pulmonary fibrosis | 7.3 | 112 | Citations (PDF) |
| 165 | Comparison of the antifibrotic effects of the pan-histone deacetylase-inhibitor panobinostat versus the IPF-drug pirfenidone in fibroblasts from patients with idiopathic pulmonary fibrosis | 2.4 | 51 | Citations (PDF) |
| 166 | Evaluating Systolic and Diastolic Cardiac Function in Rodents Using Microscopic Computed Tomography | 3.3 | 14 | Citations (PDF) |
| 167 | A Face-Aging Smoking Prevention/Cessation Intervention for Nursery School Students in Germany: An Appearance-Focused Interventional Study | 3.1 | 7 | Citations (PDF) |
| 168 | Transcriptome profiling reveals the complexity of pirfenidone effects in idiopathic pulmonary fibrosis | 8.7 | 73 | Citations (PDF) |
| 169 | Effect of Riociguat and Sildenafil on Right Heart Remodeling and Function in Pressure Overload Induced Model of Pulmonary Arterial Banding | 2.7 | 32 | Citations (PDF) |
| 170 | Targeting transglutaminase 2 partially restores extracellular matrix structure but not alveolar architecture in experimental bronchopulmonary dysplasia | 5.5 | 20 | Citations (PDF) |
| 171 | The European IPF registry (eurIPFreg): baseline characteristics and survival of patients with idiopathic pulmonary fibrosis | 4.5 | 232 | Citations (PDF) |
| 172 | Understanding alveolarization to induce lung regeneration | 4.5 | 55 | Citations (PDF) |
| 173 | MiCEE is a ncRNA-protein complex that mediates epigenetic silencing and nucleolar organization | 25.9 | 59 | Citations (PDF) |
| 174 | Relevance of the TAPSE/PASP ratio in pulmonary arterial hypertension | 2.3 | 251 | Citations (PDF) |
| 175 | Resolvin E1 and its precursor 18R-HEPE restore mitochondrial function in inflammation | 2.4 | 23 | Citations (PDF) |
| 176 | Classical IL-6 signaling: a promising therapeutic target for pulmonary arterial hypertension | 9.0 | 61 | Citations (PDF) |
| 177 | Targeting CREB-binding protein overrides LPS induced radioresistance in non-small cell lung cancer cell lines | 1.7 | 7 | Citations (PDF) |
| 178 | Facial-Aging Mobile Apps for Smoking Prevention in Secondary Schools in Brazil: Appearance-Focused Interventional Study | 3.0 | 4 | Citations (PDF) |
| 179 | A Face-Aging App for Smoking Cessation in a Waiting Room Setting: Pilot Study in an HIV Outpatient Clinic | 4.9 | 21 | Citations (PDF) |
| 180 | Modelling bronchopulmonary dysplasia in mice: how much oxygen is enough? | 2.0 | 95 | Citations (PDF) |
| 181 | The prognostic relevance of oxygen uptake in inoperable chronic thromboembolic pulmonary hypertension | 2.2 | 7 | Citations (PDF) |
| 182 | Caffeine administration modulates TGF-β signaling but does not attenuate blunted alveolarization in a hyperoxia-based mouse model of bronchopulmonary dysplasia | 2.4 | 44 | Citations (PDF) |
| 183 | Therapeutic and pathological roles of fibroblast growth factors in pulmonary diseases | 1.8 | 29 | Citations (PDF) |
| 184 | The Giessen Pulmonary Hypertension Registry: Survival in pulmonary hypertension subgroups | 1.2 | 290 | Citations (PDF) |
| 185 | Hemodynamic phenotyping based on exercise catheterization predicts outcome in patients with heart failure and reduced ejection fraction | 1.2 | 17 | Citations (PDF) |
| 186 | Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors | 0.7 | 75 | Citations (PDF) |
| 187 | Amplified canonical transforming growth factor-β signalling<i>via</i>heat shock protein 90 in pulmonary fibrosis | 8.7 | 79 | Citations (PDF) |
| 188 | Ex vivo analysis of the contribution of FGF10<sup>+</sup> cells to airway smooth muscle cell formation during early lung development | 1.8 | 24 | Citations (PDF) |
| 189 | Stereological monitoring of mouse lung alveolarization from the early postnatal period to adulthood | 3.4 | 83 | Citations (PDF) |
| 190 | Inspiratory capacity is not altered in operable chronic thromboembolic pulmonary hypertension | 2.1 | 2 | Citations (PDF) |
| 191 | Mitochondrial Complex IV Subunit 4 Isoform 2 Is Essential for Acute Pulmonary Oxygen Sensing | 12.6 | 111 | Citations (PDF) |
| 192 | The safety and pharmacokinetics of rapid iloprost aerosol delivery via the BREELIB nebulizer in pulmonary arterial hypertension | 2.1 | 22 | Citations (PDF) |
| 193 | Identification and Functional Characterization of Hypoxia-Induced Endoplasmic Reticulum Stress Regulating lncRNA (HypERlnc) in Pericytes | 12.6 | 71 | Citations (PDF) |
| 194 | In cancer cell lines inhibition of SCF/c-Kit pathway leads to radiosensitization only when SCF is strongly over-expressed | 1.0 | 4 | Citations (PDF) |
| 195 | Lipoteichoic acids from Staphylococcus aureus stimulate proliferation of human non-small-cell lung cancer cells in vitro | 4.8 | 47 | Citations (PDF) |
| 196 | Antihistone Properties of C1 Esterase Inhibitor Protect against Lung Injury | 12.2 | 48 | Citations (PDF) |
| 197 | Maintained right ventricular pressure overload induces ventricular–arterial decoupling in mice | 2.6 | 21 | Citations (PDF) |
| 198 | TGF-β inhibits alveolar protein transport by promoting shedding, regulated intramembrane proteolysis, and transcriptional downregulation of megalin | 3.4 | 14 | Citations (PDF) |
| 199 | Mesenchymal Stem Cells in Fibrotic Disease | 17.1 | 390 | Citations (PDF) |
| 200 | Lung cancer–associated pulmonary hypertension: Role of microenvironmental inflammation based on tumor cell–immune cell cross-talk | 13.4 | 86 | Citations (PDF) |
| 201 | Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts | 2.5 | 33 | Citations (PDF) |
| 202 | Restoration of Megalin-Mediated Clearance of Alveolar Protein as a Novel Therapeutic Approach for Acute Lung Injury | 4.3 | 18 | Citations (PDF) |
| 203 | p38 MAPK Inhibition Improves Heart Function in Pressure-Loaded Right Ventricular Hypertrophy | 4.3 | 95 | Citations (PDF) |
| 204 | Two-Way Conversion between Lipogenic and Myogenic Fibroblastic Phenotypes Marks the Progression and Resolution of Lung Fibrosis | 17.1 | 288 | Citations (PDF) |
| 205 | <i>Fgf10</i> deficiency is causative for lethality in a mouse model of bronchopulmonary dysplasia | 5.0 | 61 | Citations (PDF) |
| 206 | T<scp>ranslational</scp> A<scp>dvances in the</scp> F<scp>ield of</scp> P<scp>ulmonary</scp> H<scp>ypertension</scp>.From Cancer Biology to New Pulmonary Arterial Hypertension Therapeutics. Targeting Cell Growth and Proliferation Signaling Hubs | 12.2 | 150 | Citations (PDF) |
| 207 | Use of very old donors for lung transplantation: a dual-centre retrospective analysis | 1.4 | 22 | Citations (PDF) |
| 208 | Hypercapnia Impairs ENaC Cell Surface Stability by Promoting Phosphorylation, Polyubiquitination and Endocytosis of β-ENaC in a Human Alveolar Epithelial Cell Line | 5.1 | 38 | Citations (PDF) |
| 209 | Characteristics and outcomes of a cohort hospitalized for pandemic and seasonal influenza in Germany based on nationwide inpatient data | 2.4 | 19 | Citations (PDF) |
| 210 | Redirecting tumor-associated macrophages to become tumoricidal effectors as a novel strategy for cancer therapy | 1.7 | 254 | Citations (PDF) |
| 211 | Pressure overload leads to an increased accumulation and activity of mast cells in the right ventricle | 1.7 | 45 | Citations (PDF) |
| 212 | Chronic intratracheal application of the soluble guanylyl cyclase stimulator BAY 41-8543 ameliorates experimental pulmonary hypertension | 1.7 | 10 | Citations (PDF) |
| 213 | Pulmonary endothelial cell DNA methylation signature in pulmonary arterial hypertension | 1.7 | 50 | Citations (PDF) |
| 214 | A Medical Student-Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Germany: Randomized Controlled Trial | 4.9 | 22 | Citations (PDF) |
| 215 | A Dermatologist's Ammunition in the War Against Smoking: A Photoaging App | 4.9 | 10 | Citations (PDF) |
| 216 | A Medical Student–Delivered Smoking Prevention Program, Education Against Tobacco, for Secondary Schools in Brazil: Study Protocol for a Randomized Trial | 1.3 | 14 | Citations (PDF) |
| 217 | Influenza Virus Infects Epithelial Stem/Progenitor Cells of the Distal Lung: Impact on Fgfr2b-Driven Epithelial Repair | 4.5 | 132 | Citations (PDF) |
| 218 | Heart rate response during 6-minute walking testing predicts outcome in operable chronic thromboembolic pulmonary hypertension | 2.6 | 16 | Citations (PDF) |
| 219 | Non‐invasive lung cancer diagnosis by detection of<i><scp>GATA</scp>6</i>and<i><scp>NKX</scp>2‐1</i>isoforms in exhaled breath condensate | 7.3 | 35 | Citations (PDF) |
| 220 | Photoaging smartphone app promoting poster campaign to reduce smoking prevalence in secondary schools: the Smokerface Randomized Trial: design and baseline characteristics | 2.0 | 35 | Citations (PDF) |
| 221 | Relevance of Angiopoietin‐2 and Soluble P‐Selectin Levels in Patients with Pulmonary Arterial Hypertension Receiving Combination Therapy with Oral Treprostinil: A FREEDOM‐C2 Biomarker Substudy | 2.1 | 9 | Citations (PDF) |
| 222 | Cancer cell motility is affected through 3D cell culturing and SCF/c-Kit pathway but not by X-irradiation | 2.0 | 5 | Citations (PDF) |
| 223 | The emerging role of epigenetics in pulmonary hypertension | 8.7 | 45 | Citations (PDF) |
| 224 | Notch1 signalling regulates endothelial proliferation and apoptosis in pulmonary arterial hypertension | 8.7 | 106 | Citations (PDF) |
| 225 | Biomarkers of tissue remodeling predict survival in patients with pulmonary hypertension | 2.3 | 23 | Citations (PDF) |
| 226 | N-3 vs. n-6 fatty acids differentially influence calcium signalling and adhesion of inflammatory activated monocytes: impact of lipid rafts | 5.0 | 17 | Citations (PDF) |
| 227 | The prognostic impact of thyroid function in pulmonary hypertension | 1.2 | 32 | Citations (PDF) |
| 228 | Survival with sildenafil and inhaled iloprost in a cohort with pulmonary hypertension: an observational study | 2.6 | 13 | Citations (PDF) |
| 229 | Soluble guanylate cyclase stimulator riociguat and phosphodiesterase 5 inhibitor sildenafil ameliorate pulmonary hypertension due to left heart disease in mice | 2.3 | 32 | Citations (PDF) |
| 230 | Epigenetic mechanisms in pulmonary arterial hypertension: the need for global perspectives | 8.8 | 48 | Citations (PDF) |
| 231 | Prolonged vasodilatory response to nanoencapsulated sildenafil in pulmonary hypertension | 3.7 | 23 | Citations (PDF) |
| 232 | Effects of carbon monoxide-releasing molecules on pulmonary vasoreactivity in isolated perfused lungs | 3.2 | 10 | Citations (PDF) |
| 233 | miR-223–IGF-IR signalling in hypoxia- and load-induced right-ventricular failure: a novel therapeutic approach | 5.5 | 60 | Citations (PDF) |
| 234 | Potential of the isolated lung technique for the examination of sildenafil absorption from lung-delivered poly(lactide- co -glycolide) microparticles | 11.1 | 15 | Citations (PDF) |
| 235 | Influence of amine-modified poly(vinyl alcohol)s on vibrating-membrane nebulizer performance and lung toxicity | 4.4 | 6 | Citations (PDF) |
| 236 | FXYD1 negatively regulates Na+/K+-ATPase activity in lung alveolar epithelial cells | 1.5 | 19 | Citations (PDF) |
| 237 | Exercise training improves peak oxygen consumption and haemodynamics in patients with severe pulmonary arterial hypertension and inoperable chronic thrombo-embolic pulmonary hypertension: a prospective, randomized, controlled trial | 2.1 | 227 | Citations (PDF) |
| 238 | Procedural safety of a fully implantable intravenous prostanoid pump for pulmonary hypertension | 3.2 | 17 | Citations (PDF) |
| 239 | Macrophage-epithelial paracrine crosstalk inhibits lung edema clearance during influenza infection | 9.0 | 118 | Citations (PDF) |
| 240 | The Clinical Significance of HbA1c in Operable Chronic Thromboembolic Pulmonary Hypertension | 2.4 | 9 | Citations (PDF) |
| 241 | Circulating Angiopoietin-1 Is Not a Biomarker of Disease Severity or Prognosis in Pulmonary Hypertension | 2.4 | 11 | Citations (PDF) |
| 242 | Innovative formulations for controlled drug delivery to the lungs and the technical and toxicological challenges to overcome<sup>#</sup> | 2.2 | 8 | Citations (PDF) |
| 243 | Photoaging Mobile Apps in School-Based Tobacco Prevention: The Mirroring Approach | 4.9 | 43 | Citations (PDF) |
| 244 | Evaluation of the prognostic value of electrocardiography parameters and heart rhythm in patients with pulmonary hypertension | 1.3 | 23 | Citations (PDF) |
| 245 | Immunomodulation by lipid emulsions in pulmonary inflammation: a randomized controlled trial | 8.1 | 39 | Citations (PDF) |
| 246 | Increased FGF1-FGFRc expression in idiopathic pulmonary fibrosis | 4.5 | 115 | Citations (PDF) |
| 247 | Increased S100A4 expression in the vasculature of human COPD lungs and murine model of smoke-induced emphysema | 4.5 | 37 | Citations (PDF) |
| 248 | Characterization of lung-delivered in-situ forming controlled release formulations | 3.0 | 8 | Citations (PDF) |
| 249 | Heart Rate Variability is Related to Disease Severity in Children and Young Adults with Pulmonary Hypertension | 1.9 | 20 | Citations (PDF) |
| 250 | Immune and Inflammatory Cell Composition of Human Lung Cancer Stroma | 2.4 | 113 | Citations (PDF) |
| 251 | 5-HT2B Receptor Antagonists Inhibit Fibrosis and Protect from RV Heart Failure | 2.7 | 76 | Citations (PDF) |
| 252 | Peritoneal ultrafiltration for refractory fluid overload and ascites due to pulmonary arterial hypertension | 1.6 | 2 | Citations (PDF) |
| 253 | Cardio-Pulmonary-Renal Interactions | 2.4 | 186 | Citations (PDF) |
| 254 | The H<sub>2</sub>S-generating enzymes cystathionine β-synthase and cystathionine γ-lyase play a role in vascular development during normal lung alveolarization | 3.4 | 48 | Citations (PDF) |
| 255 | Regulation of macroautophagy in amiodarone‐induced pulmonary fibrosis | 3.4 | 32 | Citations (PDF) |
| 256 | Macrophage and Cancer Cell Cross-talk via CCR2 and CX3CR1 Is a Fundamental Mechanism Driving Lung Cancer | 12.2 | 245 | Citations (PDF) |
| 257 | Acute Hemodynamic Effects of Nebulized Iloprost via the I‐Neb Adaptive Aerosol Delivery System in Pulmonary Hypertension | 2.1 | 12 | Citations (PDF) |
| 258 | Sildenafil versus Nitric Oxide for Acute Vasodilator Testing in Pulmonary Arterial Hypertension | 2.1 | 17 | Citations (PDF) |
| 259 | Collagen and elastin cross-linking is altered during aberrant late lung development associated with hyperoxia | 3.4 | 69 | Citations (PDF) |
| 260 | High mobility group protein-mediated transcription requires DNA damage marker γ-H2AX | 15.8 | 85 | Citations (PDF) |
| 261 | PPAR-α activation reduced LPS-induced inflammation in alveolar epithelial cells | 1.7 | 30 | Citations (PDF) |
| 262 | Systematic aging of degradable nanosuspension ameliorates vibrating-mesh nebulizer performance | 2.2 | 2 | Citations (PDF) |
| 263 | Chymase: a multifunctional player in pulmonary hypertension associated with lung fibrosis | 8.7 | 48 | Citations (PDF) |
| 264 | Poor sleep quality is associated with exercise limitation in precapillary pulmonary hypertension | 2.6 | 14 | Citations (PDF) |
| 265 | Streptococcus pneumoniae triggers progression of pulmonary fibrosis through pneumolysin | 5.8 | 91 | Citations (PDF) |
| 266 | Barriers to new drug development in respiratory disease | 8.7 | 110 | Citations (PDF) |
| 267 | Education Against Tobacco (EAT): a quasi-experimental prospective evaluation of a multinational medical-student-delivered smoking prevention programme for secondary schools in Germany | 2.0 | 30 | Citations (PDF) |
| 268 | New potential diagnostic biomarkers for pulmonary hypertension | 8.7 | 34 | Citations (PDF) |
| 269 | Aberrant expression and activity of histone deacetylases in sporadic idiopathic pulmonary fibrosis | 5.8 | 127 | Citations (PDF) |
| 270 | Cigarette Smoke-Induced Emphysema and Pulmonary Hypertension Can Be Prevented by Phosphodiesterase 4 and 5 Inhibition in Mice | 2.4 | 35 | Citations (PDF) |
| 271 | Photoaging Mobile Apps: A Novel Opportunity for Smoking Cessation? | 4.9 | 22 | Citations (PDF) |
| 272 | Hypoxia- or PDGF-BB-dependent paxillin tyrosine phosphorylation in pulmonary hypertension is reversed by HIF-1α depletion or imatinib treatment | 4.2 | 20 | Citations (PDF) |
| 273 | Transglutaminase 2: a new player in bronchopulmonary dysplasia? | 8.7 | 30 | Citations (PDF) |
| 274 | Interactions between neutrophils and non-small cell lung cancer cells: enhancement of tumor proliferation and inflammatory mediator synthesis | 4.8 | 73 | Citations (PDF) |
| 275 | Carbon ion radiotherapy of human lung cancer attenuates HIF‐1 signaling and acts with considerably enhanced therapeutic efficiency | 0.7 | 50 | Citations (PDF) |
| 276 | Systemic hydrogen sulfide administration partially restores normal alveolarization in an experimental animal model of bronchopulmonary dysplasia | 3.4 | 49 | Citations (PDF) |
| 277 | Histological Characterization of Mast Cell Chymase in Patients with Pulmonary Hypertension and Chronic Obstructive Pulmonary Disease | 2.1 | 43 | Citations (PDF) |
| 278 | Education Against Tobacco (EAT): a quasi-experimental prospective evaluation of a programme for preventing smoking in secondary schools delivered by medical students: a study protocol | 2.0 | 19 | Citations (PDF) |
| 279 | Stimulation of Soluble Guanylate Cyclase Prevents Cigarette Smoke–induced Pulmonary Hypertension and Emphysema | 12.2 | 88 | Citations (PDF) |
| 280 | Altered Surfactant Homeostasis and Alveolar Epithelial Cell Stress in Amiodarone-Induced Lung Fibrosis | 3.9 | 47 | Citations (PDF) |
| 281 | Lysyl Oxidases Play a Causal Role in Vascular Remodeling in Clinical and Experimental Pulmonary Arterial Hypertension | 6.4 | 114 | Citations (PDF) |
| 282 | Structural and functional prevention of hypoxia-induced pulmonary hypertension by individualized exercise training in mice | 3.4 | 32 | Citations (PDF) |
| 283 | Hmga2is required for canonical WNT signaling during lung development | 4.0 | 60 | Citations (PDF) |
| 284 | Arterial hypertension in a murine model of sleep apnea | 2.3 | 48 | Citations (PDF) |
| 285 | TGF-β directs trafficking of the epithelial sodium channel ENaC which has implications for ion and fluid transport in acute lung injury | 7.8 | 142 | Citations (PDF) |
| 286 | Elimination of B-RAF in Oncogenic C-RAF-expressing Alveolar Epithelial Type II Cells Reduces MAPK Signal Intensity and Lung Tumor Growth | 2.3 | 10 | Citations (PDF) |
| 287 | Controlling the droplet size of formulations nebulized by vibrating-membrane technology | 4.1 | 22 | Citations (PDF) |
| 288 | Impact of S-Adenosylmethionine Decarboxylase 1 on Pulmonary Vascular Remodeling | 25.3 | 24 | Citations (PDF) |
| 289 | <i>Fgf10</i>-positive cells represent a progenitor cell population during lung development and postnatally | 3.0 | 146 | Citations (PDF) |
| 290 | Phenotypical and ultrastructural features of Oct4‐positive cells in the adult mouse lung | 4.1 | 39 | Citations (PDF) |
| 291 | Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension | 40.4 | 273 | Citations (PDF) |
| 292 | Biophysical inhibition of pulmonary surfactant function by polymeric nanoparticles: Role of surfactant protein B and C | 9.4 | 29 | Citations (PDF) |
| 293 | Senescence-Associated Secretory Phenotype and Its Possible Role in Chronic Obstructive Pulmonary Disease | 4.3 | 115 | Citations (PDF) |
| 294 | Impact of Short‐ and Medium‐Chain Fatty Acids on Mitochondrial Function in Severe Inflammation | 3.4 | 46 | Citations (PDF) |
| 295 | Deregulation of the lysyl hydroxylase matrix cross-linking system in experimental and clinical bronchopulmonary dysplasia | 3.4 | 48 | Citations (PDF) |
| 296 | On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery | 4.8 | 28 | Citations (PDF) |
| 297 | <i>miR-142-3p</i>balances proliferation and differentiation of mesenchymal cells during lung development | 3.0 | 73 | Citations (PDF) |
| 298 | Biophysical inhibition of synthetic vs. naturally-derived pulmonary surfactant preparations by polymeric nanoparticles | 2.2 | 61 | Citations (PDF) |
| 299 | Boosting the aerodynamic properties of vibrating-mesh nebulized polymeric nanosuspensions | 4.8 | 24 | Citations (PDF) |
| 300 | Glucocorticoids Recruit Tgfbr3 and Smad1 to Shift Transforming Growth Factor-β Signaling from the Tgfbr1/Smad2/3 Axis to the Acvrl1/Smad1 Axis in Lung Fibroblasts | 2.3 | 58 | Citations (PDF) |
| 301 | Novel and Emerging Therapies for Pulmonary Hypertension | 12.2 | 81 | Citations (PDF) |
| 302 | MicroRNA-124 Controls the Proliferative, Migratory, and Inflammatory Phenotype of Pulmonary Vascular Fibroblasts | 12.6 | 205 | Citations (PDF) |
| 303 | Immunomodulation by fish-oil containing lipid emulsions in murine acute respiratory distress syndrome | 8.1 | 27 | Citations (PDF) |
| 304 | Mitochondrial Hyperpolarization in Pulmonary Vascular Remodeling. Mitochondrial Uncoupling Protein Deficiency as Disease Model | 4.3 | 72 | Citations (PDF) |
| 305 | Correlation of drug release with pulmonary drug absorption profiles for nebulizable liposomal formulations | 4.1 | 35 | Citations (PDF) |
| 306 | Pulmonary Hypertension Due to Left Heart Diseases | 2.4 | 580 | Citations (PDF) |
| 307 | Effects of multikinase inhibitors on pressure overload-induced right ventricular remodeling | 2.3 | 38 | Citations (PDF) |
| 308 | Efficient gene delivery to primary alveolar epithelial cells by nucleofection | 3.4 | 15 | Citations (PDF) |
| 309 | Updated Treatment Algorithm of Pulmonary Arterial Hypertension | 2.4 | 618 | Citations (PDF) |
| 310 | Pulmonary Hypertension in Chronic Lung Diseases | 2.4 | 596 | Citations (PDF) |
| 311 | Function of NADPH Oxidase 1 in Pulmonary Arterial Smooth Muscle Cells After Monocrotaline-Induced Pulmonary Vascular Remodeling | 6.5 | 73 | Citations (PDF) |
| 312 | Cofilin, a hypoxia‐regulated protein in murine lungs identified by 2<scp>DE</scp>: Role of the cytoskeletal protein cofilin in pulmonary hypertension | 3.2 | 16 | Citations (PDF) |
| 313 | Comparative proteome analysis of lung tissue from patients with idiopathic pulmonary fibrosis (IPF), non-specific interstitial pneumonia (NSIP) and organ donors | 2.4 | 71 | Citations (PDF) |
| 314 | Sleep apnea in precapillary pulmonary hypertension | 1.8 | 82 | Citations (PDF) |
| 315 | Macrophage-expressed IFN-β Contributes to Apoptotic Alveolar Epithelial Cell Injury in Severe Influenza Virus Pneumonia | 4.5 | 226 | Citations (PDF) |
| 316 | Effects of Dimethylarginine Dimethylaminohydrolase–1 Overexpression on the Response of the Pulmonary Vasculature to Hypoxia | 4.3 | 17 | Citations (PDF) |
| 317 | Quantitative Proteome Analysis of Alveolar Type-II Cells Reveals a Connection of Integrin Receptor Subunits Beta 2/6 and WNT Signaling | 3.6 | 10 | Citations (PDF) |
| 318 | Classical Transient Receptor Potential Channel 1 in Hypoxia-induced Pulmonary Hypertension | 12.2 | 82 | Citations (PDF) |
| 319 | Short‐Term Improvement in Pulmonary Hemodynamics is Strongly Predictive of Long‐Term Survival in Patients with Pulmonary Arterial Hypertension | 2.1 | 23 | Citations (PDF) |
| 320 | Obstructive Sleep Apnea, Oxidative Stress and Cardiovascular Disease: Lessons from Animal Studies | 4.7 | 104 | Citations (PDF) |
| 321 | Pivotal Role of Matrix Metalloproteinase 13 in Extracellular Matrix Turnover in Idiopathic Pulmonary Fibrosis | 2.4 | 88 | Citations (PDF) |
| 322 | Differential Effects of Drugs Targeting Cancer Stem Cell (CSC) and Non-CSC Populations on Lung Primary Tumors and Metastasis | 2.4 | 77 | Citations (PDF) |
| 323 | Influence of Early Growth Response 1 (Egr1) and Tenascin C (Tnc) on compensatory lung growth | 0.7 | 0 | Citations (PDF) |
| 324 | Role of Src Tyrosine Kinases in Experimental Pulmonary Hypertension | 6.4 | 117 | Citations (PDF) |
| 325 | Inhibition of MicroRNA-17 Improves Lung and Heart Function in Experimental Pulmonary Hypertension | 12.2 | 223 | Citations (PDF) |
| 326 | PAR-2 Inhibition Reverses Experimental Pulmonary Hypertension | 12.6 | 65 | Citations (PDF) |
| 327 | Immune and Inflammatory Cell Involvement in the Pathology of Idiopathic Pulmonary Arterial Hypertension | 12.2 | 371 | Citations (PDF) |
| 328 | Micro-computed tomography imaging of composite nanoparticle distribution in the lung | 4.8 | 7 | Citations (PDF) |
| 329 | BDNF/TrkB Signaling Augments Smooth Muscle Cell Proliferation in Pulmonary Hypertension | 3.5 | 48 | Citations (PDF) |
| 330 | E-cadherin Controls Bronchiolar Progenitor Cells and Onset of Preneoplastic Lesions in Mice | 7.2 | 31 | Citations (PDF) |
| 331 | Activation of TRPC6 channels is essential for lung ischaemia–reperfusion induced oedema in mice | 13.9 | 172 | Citations (PDF) |
| 332 | Dynamic hyperinflation during exercise in patients with precapillary pulmonary hypertension | 2.8 | 30 | Citations (PDF) |
| 333 | Megalin mediates transepithelial albumin clearance from the alveolar space of intact rabbit lungs | 3.1 | 34 | Citations (PDF) |
| 334 | Paxillin Regulates Pulmonary Arterial Smooth Muscle Cell Function in Pulmonary Hypertension | 3.5 | 29 | Citations (PDF) |
| 335 | Impact of lyoprotectants for the stabilization of biodegradable nanoparticles on the performance of air-jet, ultrasonic, and vibrating-mesh nebulizers | 4.1 | 59 | Citations (PDF) |
| 336 | HbA1c in pulmonary arterial hypertension: A marker of prognostic relevance? | 1.2 | 42 | Citations (PDF) |
| 337 | The Soluble Guanylate Cyclase Stimulator Riociguat Ameliorates Pulmonary Hypertension Induced by Hypoxia and SU5416 in Rats | 2.4 | 107 | Citations (PDF) |
| 338 | Matrix metalloproteinases and their inhibitors in pulmonary hypertension | 8.7 | 145 | Citations (PDF) |
| 339 | Hypoxia induces Kv channel current inhibition by increased NADPH oxidase-derived reactive oxygen species | 3.8 | 71 | Citations (PDF) |
| 340 | Nebulization performance of biodegradable sildenafil-loaded nanoparticles using the Aeroneb® Pro: Formulation aspects and nanoparticle stability to nebulization | 4.8 | 70 | Citations (PDF) |
| 341 | Development of a biodegradable nanoparticle platform for sildenafil: Formulation optimization by factorial design analysis combined with application of charge-modified branched polyesters | 11.1 | 56 | Citations (PDF) |
| 342 | Characterization of novel spray-dried polymeric particles for controlled pulmonary drug delivery | 11.1 | 127 | Citations (PDF) |
| 343 | Effects of hypercapnia and NO synthase inhibition in sustained hypoxic pulmonary vasoconstriction | 4.5 | 21 | Citations (PDF) |
| 344 | Endotoxin induces proliferation of NSCLC in vitro and in vivo: role of COX-2 and EGFR activation | 4.8 | 49 | Citations (PDF) |
| 345 | Following the Concentration of Polymeric Nanoparticles During Nebulization | 3.8 | 31 | Citations (PDF) |
| 346 | Alveolar epithelial cells orchestrate DC function in murine viral pneumonia | 9.0 | 98 | Citations (PDF) |
| 347 | Evolutionary Conserved Role of c-Jun-N-Terminal Kinase in CO2-Induced Epithelial Dysfunction | 2.4 | 45 | Citations (PDF) |
| 348 | Comparative Proteomic Analysis of Lung Tissue from Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lung Transplant Donor Lungs | 3.6 | 94 | Citations (PDF) |
| 349 | Inducible NOS Inhibition Reverses Tobacco-Smoke-Induced Emphysema and Pulmonary Hypertension in Mice | 34.4 | 326 | Citations (PDF) |
| 350 | Long-term effects of inhaled treprostinil in patients with pulmonary arterial hypertension: The TReprostinil sodium Inhalation Used in the Management of Pulmonary arterial Hypertension (TRIUMPH) study open-label extension | 1.2 | 109 | Citations (PDF) |
| 351 | Phosphodiesterase 10A Upregulation Contributes to Pulmonary Vascular Remodeling | 2.4 | 44 | Citations (PDF) |
| 352 | Expression of B-RAF V600E in Type II Pneumocytes Causes Abnormalities in Alveolar Formation, Airspace Enlargement and Tumor Formation in Mice | 2.4 | 3 | Citations (PDF) |
| 353 | The potential for inhaled treprostinil in the treatment of pulmonary arterial hypertension | 2.8 | 23 | Citations (PDF) |
| 354 | Diacylglycerol regulates acute hypoxic pulmonary vasoconstriction via TRPC6 | 4.5 | 54 | Citations (PDF) |
| 355 | Involvement of mast cells in monocrotaline-induced pulmonary hypertension in rats | 4.5 | 70 | Citations (PDF) |
| 356 | Therapeutic efficacy of TBC3711 in monocrotaline-induced pulmonary hypertension | 4.5 | 19 | Citations (PDF) |
| 357 | Hemodynamic and clinical onset in patients with hereditary pulmonary arterial hypertension and BMPR2 mutations | 4.5 | 64 | Citations (PDF) |
| 358 | Amphiphilic, low molecular weight poly(ethylene imine) derivatives with enhanced stability for efficient pulmonary gene delivery | 2.5 | 33 | Citations (PDF) |
| 359 | Comparison of the Effects of Carbon Ion and Photon Irradiation on the Angiogenic Response in Human Lung Adenocarcinoma Cells | 1.6 | 40 | Citations (PDF) |
| 360 | Biophysical investigation of pulmonary surfactant surface properties upon contact with polymeric nanoparticles in vitro | 3.7 | 108 | Citations (PDF) |
| 361 | Shedding of Low-Density Lipoprotein Receptor–related Protein-1 in Acute Respiratory Distress Syndrome | 12.2 | 42 | Citations (PDF) |
| 362 | Nitric Oxide Inhibits Highly Selective Sodium Channels and the Na<sup>+</sup>/K<sup>+</sup>-ATPase in H441 Cells | 4.3 | 39 | Citations (PDF) |
| 363 | Effects of short-term infusion of lipid emulsions on pro-inflammatory cytokines and lymphocyte apoptosis in septic and non-septic rats | 2.5 | 1 | Citations (PDF) |
| 364 | Treprostinil Inhibits the Adhesion and Differentiation of Fibrocytes via the Cyclic Adenosine Monophosphate–Dependent and Ras-Proximate Protein–Dependent Inactivation of Extracellular Regulated Kinase | 4.3 | 32 | Citations (PDF) |
| 365 | cAMP Phosphodiesterase Inhibitors Increases Nitric Oxide Production by Modulating Dimethylarginine Dimethylaminohydrolases | 25.3 | 46 | Citations (PDF) |
| 366 | Hypoxic Pulmonary Hypertension in Mice with Constitutively Active Platelet‐Derived Growth Factor Receptor‐β | 2.1 | 51 | Citations (PDF) |
| 367 | Neurotrophic Tyrosine Kinase Receptor B/Neurotrophin 4 Signaling Axis Is Perturbed in Clinical and Experimental Pulmonary Fibrosis | 4.3 | 22 | Citations (PDF) |
| 368 | Exudate Macrophages Attenuate Lung Injury by the Release of IL-1 Receptor Antagonist in Gram-negative Pneumonia | 12.2 | 103 | Citations (PDF) |
| 369 | The Role of Dimethylarginine Dimethylaminohydrolase in Idiopathic Pulmonary Fibrosis | 13.4 | 69 | Citations (PDF) |
| 370 | Evaluating the Controlled Release Properties of Inhaled Nanoparticles Using Isolated, Perfused, and Ventilated Lung Models | 2.9 | 26 | Citations (PDF) |
| 371 | Air Travel Can Be Safe and Well Tolerated in Patients with Clinically Stable Pulmonary Hypertension | 2.1 | 24 | Citations (PDF) |
| 372 | Glycogen Synthase Kinase 3beta Contributes to Proliferation of Arterial Smooth Muscle Cells in Pulmonary Hypertension | 2.4 | 39 | Citations (PDF) |
| 373 | Dry powder aerosolization of a recombinant surfactant protein-C–based surfactant for inhalative treatment of the acutely inflamed lung* | 0.7 | 38 | Citations (PDF) |
| 374 | Amine-Modified Poly(Vinyl Alcohol)s as Non-viral Vectors for siRNA Delivery: Effects of the Degree of Amine Substitution on Physicochemical Properties and Knockdown Efficiency | 3.8 | 23 | Citations (PDF) |
| 375 | Redox signaling and reactive oxygen species in hypoxic pulmonary vasoconstriction | 1.5 | 37 | Citations (PDF) |
| 376 | HIF-1α signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells | 3.8 | 140 | Citations (PDF) |
| 377 | Novel ‘Nano in Nano’ Composites for Sustained Drug Delivery: Biodegradable Nanoparticles Encapsulated into Nanofiber Non‐Wovens | 4.0 | 57 | Citations (PDF) |
| 378 | Effects of phosphodiesterase 4 inhibition on bleomycin-induced pulmonary fibrosis in mice | 2.6 | 43 | Citations (PDF) |
| 379 | Increased expression of 5-hydroxytryptamine2A/B receptors in idiopathic pulmonary fibrosis: a rationale for therapeutic intervention | 5.8 | 71 | Citations (PDF) |
| 380 | TIAR and TIA-1 mRNA-Binding Proteins Co-aggregate under Conditions of Rapid Oxygen Decline and Extreme Hypoxia and Suppress the HIF-1 Pathway | 3.6 | 46 | Citations (PDF) |
| 381 | Role of Epidermal Growth Factor Inhibition in Experimental Pulmonary Hypertension | 12.2 | 128 | Citations (PDF) |
| 382 | Safety and Tolerability of Inhaled Heparin in Idiopathic Pulmonary Fibrosis | 1.8 | 57 | Citations (PDF) |
| 383 | Worldwide Physician Education and Training in Pulmonary HypertensionChest, 2010, 137, 85S-94S | 1.1 | 29 | Citations (PDF) |
| 384 | INDUCTION OF LYMPHOCYTE APOPTOSIS IN A MURINE MODEL OF ACUTE LUNG INJURY-MODULATION BY LIPID EMULSIONS | 2.4 | 15 | Citations (PDF) |
| 385 | Inhibition of Urokinase Activity Reduces Primary Tumor Growth and Metastasis Formation in a Murine Lung Carcinoma Model | 12.2 | 48 | Citations (PDF) |
| 386 | Dysregulation of the IL-13 Receptor System. A Novel Pathomechanism in Pulmonary Arterial Hypertension | 12.2 | 65 | Citations (PDF) |
| 387 | Epithelial Stress and Apoptosis Underlie Hermansky-Pudlak Syndrome–associated Interstitial Pneumonia | 12.2 | 92 | Citations (PDF) |
| 388 | Pulmonary Targeting with Biodegradable Salbutamol-Loaded Nanoparticles | 1.8 | 63 | Citations (PDF) |
| 389 | Animal models of pulmonary hypertension: role in translational research | 1.8 | 11 | Citations (PDF) |
| 390 | Addition of Inhaled Treprostinil to Oral Therapy for Pulmonary Arterial Hypertension | 2.4 | 539 | Citations (PDF) |
| 391 | Phosphodiesterase 6 subunits are expressed and altered in idiopathic pulmonary fibrosis | 4.5 | 24 | Citations (PDF) |
| 392 | Nebulization of the acidified sodium nitrite formulation attenuates acute hypoxic pulmonary vasoconstriction | 4.5 | 14 | Citations (PDF) |
| 393 | Long-term therapy with inhaled iloprost in patients with pulmonary hypertension | 2.8 | 75 | Citations (PDF) |
| 394 | Identification of right heart-enriched genes in a murine model of chronic outflow tract obstruction | 3.8 | 58 | Citations (PDF) |
| 395 | Riociguat for Pulmonary Hypertension | 1.1 | 30 | Citations (PDF) |
| 396 | Stress Doppler Echocardiography in Relatives of Patients With Idiopathic and Familial Pulmonary Arterial Hypertension | 25.3 | 219 | Citations (PDF) |
| 397 | Enhanced gene expression and reduced toxicity in mice using polyplexes of low-molecular-weight poly(ethylene imine) for pulmonary gene delivery | 3.6 | 24 | Citations (PDF) |
| 398 | Expression and Activity of Phosphodiesterase Isoforms during Epithelial Mesenchymal Transition: The Role of Phosphodiesterase 4 | 2.5 | 92 | Citations (PDF) |
| 399 | Heme Oxygenase-2 and Large-Conductance Ca<sup>2+</sup>-activated K<sup>+</sup> Channels | 12.2 | 38 | Citations (PDF) |
| 400 | Surface expression of CD74 by type II alveolar epithelial cells: a potential mechanism for macrophage migration inhibitory factor-induced epithelial repair | 3.4 | 103 | Citations (PDF) |
| 401 | Acute Lung Injury Is Reduced in <i>fat-1</i> Mice Endogenously Synthesizing n-3 Fatty Acids | 12.2 | 53 | Citations (PDF) |
| 402 | Macrophage Tumor Necrosis Factor-α Induces Epithelial Expression of Granulocyte–Macrophage Colony-stimulating Factor | 12.2 | 124 | Citations (PDF) |
| 403 | Evidence of Dysfunction of Endothelial Progenitors in Pulmonary Arterial Hypertension | 12.2 | 220 | Citations (PDF) |
| 404 | The Noncanonical WNT Pathway Is Operative in Idiopathic Pulmonary Arterial Hypertension | 4.3 | 98 | Citations (PDF) |
| 405 | Lysyl Oxidase Activity Is Dysregulated during Impaired Alveolarization of Mouse and Human Lungs | 12.2 | 87 | Citations (PDF) |
| 406 | Effects of hypercapnia with and without acidosis on hypoxic pulmonary vasoconstriction | 3.4 | 68 | Citations (PDF) |
| 407 | The soluble guanylate cyclase activator HMR1766 reverses hypoxia-induced experimental pulmonary hypertension in mice | 3.4 | 36 | Citations (PDF) |
| 408 | Genome-wide transcriptional profiling of mononuclear phagocytes recruited to mouse lungs in response to alveolar challenge with the TLR2 agonist Pam3CSK4 | 3.4 | 10 | Citations (PDF) |
| 409 | Novel soluble guanylyl cyclase stimulator BAY 41-2272 attenuates ischemia-reperfusion-induced lung injury | 3.4 | 22 | Citations (PDF) |
| 410 | Carbon Monoxide Rapidly Impairs Alveolar Fluid Clearance by Inhibiting Epithelial Sodium Channels | 4.3 | 63 | Citations (PDF) |
| 411 | Amplification of Lipopolysaccharide-Induced Cytokine Synthesis in Non–Small Cell Lung Cancer/Neutrophil Cocultures | 3.5 | 14 | Citations (PDF) |
| 412 | Nanocomposites of lung surfactant and biodegradable cationic nanoparticles improve transfection efficiency to lung cells | 11.1 | 53 | Citations (PDF) |
| 413 | Pulmonary drug delivery with aerosolizable nanoparticles in an ex vivo lung model | 4.8 | 113 | Citations (PDF) |
| 414 | Metered dose inhaler delivery of treprostinil for the treatment of pulmonary hypertension | 2.4 | 43 | Citations (PDF) |
| 415 | End Points and Clinical Trial Design in Pulmonary Arterial Hypertension | 2.4 | 215 | Citations (PDF) |
| 416 | Serum matrix metalloproteinases in adult CF patients: Relation to pulmonary exacerbation | 0.8 | 58 | Citations (PDF) |
| 417 | Transcriptome profiling of primary murine monocytes, lung macrophages and lung dendritic cells reveals a distinct expression of genes involved in cell trafficking | 4.5 | 31 | Citations (PDF) |
| 418 | Evaluation of Angiogenesis Using Micro-Computed Tomography in a Xenograft Mouse Model of Lung Cancer | 7.2 | 95 | Citations (PDF) |
| 419 | Alveolar Oxidative Stress is Associated with Elevated Levels of Nonenzymatic Low-Molecular-Weight Antioxidants in Patients with Different Forms of Chronic Fibrosing Interstitial Lung Diseases | 6.5 | 50 | Citations (PDF) |
| 420 | Staphylococcus aureus α-toxin and Escherichia coli hemolysin impair cardiac regional perfusion and contractile function by activating myocardial eicosanoid metabolism in isolated rat hearts | 0.7 | 14 | Citations (PDF) |
| 421 | WNT1-inducible signaling protein–1 mediates pulmonary fibrosis in mice and is upregulated in humans with idiopathic pulmonary fibrosis | 9.0 | 468 | Citations (PDF) |
| 422 | Direct and simultaneous profiling of epoxyeicosatrienoic acid enantiomers by capillary tandem column chiral-phase liquid chromatography with dual online photodiode array and tandem mass spectrometric detection | 3.5 | 24 | Citations (PDF) |
| 423 | Characterization of a murine model of monocrotaline pyrrole-induced acute lung injury | 2.6 | 46 | Citations (PDF) |
| 424 | Effects of cell‐penetrating peptides and pegylation on transfection efficiency of polyethylenimine in mouse lungs | 2.5 | 80 | Citations (PDF) |
| 425 | TGF‐β signaling is dynamically regulated during the alveolarization of rodent and human lungs | 1.8 | 93 | Citations (PDF) |
| 426 | Pulmonary absorption of aerosolized fluorescent markers in the isolated rabbit lung | 4.8 | 20 | Citations (PDF) |
| 427 | Executive functions and cognitive subprocesses in patients with obstructive sleep apnoea | 4.0 | 66 | Citations (PDF) |
| 428 | Acute effects of the combination of sildenafil and inhaled treprostinil on haemodynamics and gas exchange in pulmonary hypertension | 2.4 | 70 | Citations (PDF) |
| 429 | Plasminogen activator inhibitor type 1 inhibits smooth muscle cell proliferation in pulmonary arterial hypertension | 2.7 | 36 | Citations (PDF) |
| 430 | Fatty acids differentially influence phosphatidylinositol 3-kinase signal transduction in endothelial cells: Impact on adhesion and apoptosis | 1.6 | 24 | Citations (PDF) |
| 431 | NOX4 Regulates ROS Levels Under Normoxic and Hypoxic Conditions, Triggers Proliferation, and Inhibits Apoptosis in Pulmonary Artery Adventitial Fibroblasts | 6.5 | 127 | Citations (PDF) |
| 432 | A Search for Subgroups of Patients With ARDS Who May Benefit From Surfactant Replacement TherapyChest, 2008, 134, 724-732 | 1.1 | 111 | Citations (PDF) |
| 433 | Transgelin is a direct target of TGF‐β/Smad3‐dependent epithelial cell migration in lung fibrosis | 0.7 | 135 | Citations (PDF) |
| 434 | Functional role and species-specific contribution of arginases in pulmonary fibrosis | 3.4 | 90 | Citations (PDF) |
| 435 | Fhl-1, a New Key Protein in Pulmonary Hypertension | 25.3 | 85 | Citations (PDF) |
| 436 | Epithelial Endoplasmic Reticulum Stress and Apoptosis in Sporadic Idiopathic Pulmonary Fibrosis | 12.2 | 493 | Citations (PDF) |
| 437 | Lung epithelial apoptosis in influenza virus pneumonia: the role of macrophage-expressed TNF-related apoptosis-inducing ligand | 8.0 | 357 | Citations (PDF) |
| 438 | PKR Regulates TLR2/TLR4-Dependent Signaling in Murine Alveolar Macrophages | 4.3 | 75 | Citations (PDF) |
| 439 | Spatiotemporal Expression of flk-1 in Pulmonary Epithelial Cells during Lung Development | 4.3 | 15 | Citations (PDF) |
| 440 | Role of the Prostanoid EP4 Receptor in Iloprost-mediated Vasodilatation in Pulmonary Hypertension | 12.2 | 85 | Citations (PDF) |
| 441 | Inhaled Prostanoids in the Therapy of Pulmonary Hypertension | 1.8 | 77 | Citations (PDF) |
| 442 | Fish oil in critical illness | 3.2 | 80 | Citations (PDF) |
| 443 | APOPTOSIS CONTRIBUTES TO SEPTIC CARDIOMYOPATHY AND IS IMPROVED BY SIMVASTATIN THERAPY | 2.4 | 59 | Citations (PDF) |
| 444 | The lectin-like domain of tumor necrosis factor-α improves alveolar fluid balance in injured isolated rabbit lungs* | 0.7 | 64 | Citations (PDF) |
| 445 | Recombinant production of a hybrid plasminogen activator composed of surfactant protein B and low-molecular-weight urokinase | 4.2 | 6 | Citations (PDF) |
| 446 | Functional Wnt Signaling Is Increased in Idiopathic Pulmonary Fibrosis | 2.4 | 457 | Citations (PDF) |
| 447 | Stabilization of Aerosolizable Nano-carriers by Freeze-Drying | 3.8 | 37 | Citations (PDF) |
| 448 | AMP-activated protein kinase regulates CO2-induced alveolar epithelial dysfunction in rats and human cells by promoting Na,K-ATPase endocytosis | 9.0 | 152 | Citations (PDF) |
| 449 | Inhaled Prostanoids in the Therapy of Pulmonary Hypertension | 0.0 | 0 | Citations (PDF) |
| 450 | Receptor for Activated C-Kinase 1, a Novel Interaction Partner of Type II Bone Morphogenetic Protein Receptor, Regulates Smooth Muscle Cell Proliferation in Pulmonary Arterial Hypertension | 25.3 | 50 | Citations (PDF) |
| 451 | Lung Dendritic Cells Elicited by Fms-like Tyrosin 3-Kinase Ligand Amplify the Lung Inflammatory Response to Lipopolysaccharide | 12.2 | 28 | Citations (PDF) |
| 452 | Importance of Phosphoinositide 3-Kinase γ in the Host Defense against Pneumococcal Infection | 12.2 | 75 | Citations (PDF) |
| 453 | The Angiotensin II Receptor 2 Is Expressed and Mediates Angiotensin II Signaling in Lung Fibrosis | 4.3 | 91 | Citations (PDF) |
| 454 | Hypoxia-Dependent Regulation of Nonphagocytic NADPH Oxidase Subunit NOX4 in the Pulmonary Vasculature | 12.6 | 332 | Citations (PDF) |
| 455 | Phosphodiesterase 1 Upregulation in Pulmonary Arterial Hypertension | 25.3 | 152 | Citations (PDF) |
| 456 | Hyperoxia modulates TGF-β/BMP signaling in a mouse model of bronchopulmonary dysplasia | 3.4 | 221 | Citations (PDF) |
| 457 | Immune modulation by parenteral lipids: Platelet activating factor is not the only clue | 0.7 | 2 | Citations (PDF) |
| 458 | Immunomodulation by n-3- versus n-6-rich lipid emulsions in murine acute lung injury—Role of platelet-activating factor receptor | 0.7 | 27 | Citations (PDF) |
| 459 | Effect of sildenafil on hypoxia-induced changes in pulmonary circulation and right ventricular function | 1.5 | 36 | Citations (PDF) |
| 460 | Hypoxia-induced pulmonary hypertension: Different impact of iloprost, sildenafil, and nitric oxide | 2.8 | 27 | Citations (PDF) |
| 461 | Dysregulated Bone Morphogenetic Protein Signaling in Monocrotaline-Induced Pulmonary Arterial Hypertension | 6.4 | 137 | Citations (PDF) |
| 462 | Iloprost-induced desensitization of the prostacyclin receptor in isolated rabbit lungs | 4.5 | 35 | Citations (PDF) |
| 463 | Time-dependent changes in pulmonary surfactant function and composition in acute respiratory distress syndrome due to pneumonia or aspiration | 4.5 | 68 | Citations (PDF) |
| 464 | Non-invasive screening of lung nodules in mice comparing a novel volumetric computed tomography with a clinical multislice CT | 3.0 | 3 | Citations (PDF) |
| 465 | Cellular and molecular mechanisms of hypoxia-inducible factor driven vascular remodeling | 4.2 | 84 | Citations (PDF) |
| 466 | Temporal and spatial regulation of bone morphogenetic protein signaling in late lung development | 1.8 | 37 | Citations (PDF) |
| 467 | Alveolar fluid clearance in acute lung injury: what have we learned from animal models and clinical studies? | 11.7 | 60 | Citations (PDF) |
| 468 | Direct eicosanoid profiling of the hypoxic lung by comprehensive analysis via capillary liquid chromatography with dual online photodiode-array and tandem mass-spectrometric detection | 3.5 | 25 | Citations (PDF) |
| 469 | Comparison of Pharmacokinetics and Vasodilatory Effect of Nebulized and Infused Iloprost in Experimental Pulmonary Hypertension: Rapid Tolerance Development | 0.0 | 17 | Citations (PDF) |
| 470 | Endotoxin induced peritonitis elicits monocyte immigration into the lung: implications on alveolar space inflammatory responsiveness | 4.5 | 19 | Citations (PDF) |
| 471 | DNA Transfer into Human Lung Cells Is Improved with Tat−RGD Peptide by Caveoli-Mediated Endocytosis | 3.8 | 36 | Citations (PDF) |
| 472 | Safety and Efficacy of Inhaled Treprostinil as Add-On Therapy to Bosentan in Pulmonary Arterial Hypertension | 2.4 | 118 | Citations (PDF) |
| 473 | Favorable Effects of Inhaled Treprostinil in Severe Pulmonary Hypertension | 2.4 | 139 | Citations (PDF) |
| 474 | Human RELMβ is a mitogenic factor in lung cells and induced in hypoxia | 2.8 | 35 | Citations (PDF) |
| 475 | Liver carboxylesterase cleaves surfactant protein (SP-) B and promotes surfactant subtype conversion | 2.1 | 11 | Citations (PDF) |
| 476 | Constitutive homo- and hetero-oligomerization of TβRII-B, an alternatively spliced variant of the mouse TGF-β type II receptor | 2.1 | 6 | Citations (PDF) |
| 477 | Full Length Article | 2.4 | 109 | Citations (PDF) |
| 478 | Hybrid-Primed Lymphocytes and Hybrid Vaccination Prevent Tumor Growth of Lewis Lung Carcinoma in Mice | 2.3 | 13 | Citations (PDF) |
| 479 | Pulmonary surfactant in patients with Pneumocystis pneumonia and acquired immunodeficiency syndrome | 0.7 | 27 | Citations (PDF) |
| 480 | Effect of PEGylation on the Stability of Liposomes During Nebulisation and in Lung Surfactant | 0.6 | 47 | Citations (PDF) |
| 481 | Lipoteichoic acid (LTA) from Staphylococcus aureus stimulates human neutrophil cytokine release by a CD14-dependent, Toll-like-receptor-independent mechanism: Autocrine role of tumor necrosis factor-α in mediating LTA-induced interleukin-8 generation | 0.7 | 56 | Citations (PDF) |
| 482 | Fish oil in the critically ill: from experimental to clinical data | 3.2 | 74 | Citations (PDF) |
| 483 | Free arachidonic versus eicosapentaenoic acid differentially influences the potency of bacterial exotoxins to provoke myocardial depression in isolated rat hearts | 0.7 | 36 | Citations (PDF) |
| 484 | Circulating adrenomedullin in obstructive sleep apnoea | 4.0 | 17 | Citations (PDF) |
| 485 | Lungenfibrosen—ein therapeutisches Dilemma? | 0.1 | 6 | Citations (PDF) |
| 486 | Vaskuläre Folgeerkrankungen bei obstruktiver Schlafapnoe | 0.1 | 18 | Citations (PDF) |
| 487 | Mutations of the TGF-β type II receptorBMPR2 in pulmonary arterial hypertension | 3.9 | 382 | Citations (PDF) |
| 488 | Antioxidant Vitamin C Improves Endothelial Function in Obstructive Sleep Apnea | 12.2 | 179 | Citations (PDF) |
| 489 | Genetic Association of the Serotonin Transporter in Pulmonary Arterial Hypertension | 12.2 | 90 | Citations (PDF) |
| 490 | Impact of Mitochondria and NADPH Oxidases on Acute and Sustained Hypoxic Pulmonary Vasoconstriction | 4.3 | 92 | Citations (PDF) |
| 491 | Title is missing! | 5.5 | 5 | Citations (PDF) |
| 492 | Oxygen sensors in hypoxic pulmonary vasoconstriction | 5.5 | 62 | Citations (PDF) |
| 493 | Hypoxia- and non-hypoxia-related pulmonary hypertension — Established and new therapies | 5.5 | 52 | Citations (PDF) |
| 494 | Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling | 25.3 | 219 | Citations (PDF) |
| 495 | Resident Alveolar Macrophages Are Replaced by Recruited Monocytes in Response to Endotoxin-Induced Lung Inflammation | 4.3 | 183 | Citations (PDF) |
| 496 | Systematic Comparison of the T7-IVT and SMART-Based RNA Preamplification Techniques for DNA Microarray Experiments | 1.1 | 26 | Citations (PDF) |
| 497 | Alveolar Epithelial Cells Direct Monocyte Transepithelial Migration upon Influenza Virus Infection: Impact of Chemokines and Adhesion Molecules | 0.6 | 200 | Citations (PDF) |
| 498 | Impact of HIF‐1α and HIF‐2α on proliferation and migration of human pulmonary artery fibroblasts in hypoxia | 0.7 | 55 | Citations (PDF) |
| 499 | Classical transient receptor potential channel 6 (TRPC6) is essential for hypoxic pulmonary vasoconstriction and alveolar gas exchange | 7.8 | 290 | Citations (PDF) |
| 500 | Impact of TASK-1 in Human Pulmonary Artery Smooth Muscle Cells | 12.6 | 222 | Citations (PDF) |
| 501 | Iloprost-Containing Liposomes for Aerosol Application in Pulmonary Arterial Hypertension: Formulation Aspects and Stability | 3.8 | 85 | Citations (PDF) |
| 502 | Long chain triglyceride (LCT)‐based lipid emulsions increase and olive oil(OO)‐based lipid emulsions decrease leukocyte invasion and mortality in a model of acute lung injury | 0.7 | 0 | Citations (PDF) |
| 503 | Neue Therapieoptionen in der Behandlung der pulmonalarteriellen Hypertonie | 0.8 | 3 | Citations (PDF) |
| 504 | HIV-assoziierte pulmonale Hypertonie | 0.8 | 1 | Citations (PDF) |
| 505 | Congenital erythropoietin over-expression causes “anti-pulmonary hypertensive” structural and functional changes in mice, both in normoxia and hypoxia | 4.2 | 31 | Citations (PDF) |
| 506 | CCR2-positive monocytes recruited to inflamed lungs downregulate local CCL2 chemokine levels | 3.4 | 87 | Citations (PDF) |
| 507 | Increased levels and reduced catabolism of asymmetric and symmetric dimethylarginines in pulmonary hypertension | 0.7 | 161 | Citations (PDF) |
| 508 | Inhaled Iloprost Reverses Vascular Remodeling in Chronic Experimental Pulmonary Hypertension | 12.2 | 62 | Citations (PDF) |
| 509 | The Inflammatory versus Constitutive Trafficking of Mononuclear Phagocytes into the Alveolar Space of Mice Is Associated with Drastic Changes in Their Gene Expression Profiles | 0.6 | 80 | Citations (PDF) |
| 510 | Thrombin Impairs Alveolar Fluid Clearance by Promoting Endocytosis of Na+,K+-ATPase | 4.3 | 66 | Citations (PDF) |
| 511 | Oleic Acid Inhibits Alveolar Fluid Reabsorption | 12.2 | 73 | Citations (PDF) |
| 512 | Moraxella catarrhalis–Infected Alveolar Epithelium Induced Monocyte Recruitment and Oxidative Burst | 4.3 | 16 | Citations (PDF) |
| 513 | Role of Hypoxia-Inducible Factor-1α in Hypoxia-Induced Apoptosis of Primary Alveolar Epithelial Type II Cells | 4.3 | 92 | Citations (PDF) |
| 514 | Mechanisms of Cardiac Depression Caused by Lipoteichoic Acids FromStaphylococcus aureusin Isolated Rat Hearts | 25.3 | 24 | Citations (PDF) |
| 515 | Anti-proteinase 3 antibodies (c-ANCA) prime CD14-dependent leukocyte activation | 3.0 | 27 | Citations (PDF) |
| 516 | Hypoxia‐driven proliferation of human pulmonary artery fibroblasts: cross‐talk between HIF‐1α and an autocrine angiotensin system | 0.7 | 80 | Citations (PDF) |
| 517 | HIF-1α attenuates tumor growth in spite of augmented vascularization in an A549 adenocarcinoma mouse model | 4.0 | 8 | Citations (PDF) |
| 518 | Tropolysin, a New Oligopeptidase from African Trypanosomes†,‡ | 2.8 | 11 | Citations (PDF) |
| 519 | Transforming Growth Factor-β-Dependent Growth Inhibition in Primary Vascular Smooth Muscle Cells Is p38-Dependent | 3.1 | 97 | Citations (PDF) |
| 520 | Oligopeptidase B from Trypanosoma evansi | 2.3 | 65 | Citations (PDF) |
| 521 | Identification of novel Nox4 splice variants with impact on ROS levels in A549 cells | 2.1 | 92 | Citations (PDF) |
| 522 | Analysis of Tumor Vessel Supply in Lewis Lung Carcinoma in Mice by Fluorescent Microsphere Distribution and Imaging with Micro- and Flat-Panel Computed Tomography | 3.5 | 33 | Citations (PDF) |
| 523 | Expression profiling of laser-microdissected intrapulmonary arteries in hypoxia-induced pulmonary hypertension | 4.5 | 102 | Citations (PDF) |
| 524 | Inhaled tolafentrine reverses pulmonary vascular remodeling via inhibition of smooth muscle cell migration | 4.5 | 37 | Citations (PDF) |
| 525 | Lung vasodilatory response to inhaled iloprost in experimental pulmonary hypertension: amplification by different type phosphodiesterase inhibitors | 4.5 | 32 | Citations (PDF) |
| 526 | Detection of reactive oxygen species in isolated, perfused lungs by electron spin resonance spectroscopy | 4.5 | 33 | Citations (PDF) |
| 527 | Reversal of experimental pulmonary hypertension by PDGF inhibition | 9.0 | 981 | Citations (PDF) |
| 528 | Compartment- and cell-specific expression of coagulation and fibrinolysis factors in the murine lung undergoing inhalational versus intravenous endotoxin application | 4.2 | 42 | Citations (PDF) |
| 529 | Chronic Sildenafil Treatment Inhibits Monocrotaline-induced Pulmonary Hypertension in Rats | 12.2 | 236 | Citations (PDF) |
| 530 | Antiremodeling Effects of Iloprost and the Dual-Selective Phosphodiesterase 3/4 Inhibitor Tolafentrine in Chronic Experimental Pulmonary Hypertension | 12.6 | 100 | Citations (PDF) |
| 531 | Measurement of exhaled hydrogen peroxide from rabbit lungs | 2.2 | 9 | Citations (PDF) |
| 532 | Pneumolysin-Induced Lung Injury Is Independent of Leukocyte Trafficking into the Alveolar Space | 0.6 | 80 | Citations (PDF) |
| 533 | Reversal of Nocturnal Periodic Breathing in Primary Pulmonary Hypertension After Lung TransplantationChest, 2004, 125, 344-347 | 1.1 | 14 | Citations (PDF) |
| 534 | Changes in pulmonary surfactant function and composition in bleomycin-induced pneumonitis and fibrosis | 3.3 | 47 | Citations (PDF) |
| 535 | Surfactant abnormalities after single lung transplantation in dogs: impact of bronchoscopic surfactant administration | 2.6 | 30 | Citations (PDF) |
| 536 | Bronchoscopic surfactant administration preserves gas exchange and pulmonary compliance after single lung transplantation in dogs | 2.6 | 24 | Citations (PDF) |
| 537 | Prostacyclin and its analogues in the treatment of pulmonary hypertension 2004, 102, 139-153 | | 124 | Citations (PDF) |
| 538 | Increase in alveolar antioxidant levels in hyperoxic and anoxic ventilated rabbit lungs during ischemia | 3.8 | 15 | Citations (PDF) |
| 539 | Upregulation of NAD(P)H oxidase 1 in hypoxia activates hypoxia-inducible factor 1 via increase in reactive oxygen species | 3.8 | 189 | Citations (PDF) |
| 540 | Title is missing! | 2.9 | 28 | Citations (PDF) |
| 541 | Clinical classification of pulmonary hypertension | 2.4 | 1,584 | Citations (PDF) |
| 542 | Comparative analysis of clinical trials and evidence-based treatment algorithm in pulmonary arterial hypertension | 2.4 | 212 | Citations (PDF) |
| 543 | Differences in hemodynamic and oxygenation responses to three different phosphodiesterase-5 inhibitors in patients with pulmonary arterial hypertension | 2.4 | 138 | Citations (PDF) |
| 544 | Inhibition of monocyte, lymphocyte, and neutrophil adhesion to endothelial cells by human milk oligosaccharides | 4.2 | 206 | Citations (PDF) |
| 545 | Effect of Recombinant Surfactant Protein C–Based Surfactant on the Acute Respiratory Distress Syndrome | 44.0 | 429 | Citations (PDF) |
| 546 | Basic features of hypoxic pulmonary vasoconstriction in mice | 1.5 | 61 | Citations (PDF) |
| 547 | Sildenafil Increased Exercise Capacity during Hypoxia at Low Altitudes and at Mount Everest Base Camp | 10.5 | 285 | Citations (PDF) |
| 548 | ω-3 vs. ω-6 lipid emulsions exert differential influence on neutrophils in septic shock patients: impact on plasma fatty acids and lipid mediator generation | 11.7 | 172 | Citations (PDF) |
| 549 | Central sleep apnoea and unilateral diaphragmatic paralysis associated with vertebral artery compression of the medulla oblongata | 3.9 | 19 | Citations (PDF) |
| 550 | Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features | 11.1 | 168 | Citations (PDF) |
| 551 | Impact of surface tension on the conversion rate of large to small surfactant aggregates | 2.1 | 4 | Citations (PDF) |
| 552 | Cyclooxygenase-2–Dependent and Thromboxane-Dependent Vascular and Bronchial Responses are Regulated via p38 Mitogen-Activated Protein Kinase in Control and Endotoxin-Primed Rat Lungs | 3.3 | 12 | Citations (PDF) |
| 553 | Oral sildenafil as long-term adjunct therapy to inhaled iloprost in severe pulmonary arterial hypertension | 2.4 | 367 | Citations (PDF) |
| 554 | RNA interference for HIF-1α inhibits its downstream signalling and affects cellular proliferation | 2.1 | 71 | Citations (PDF) |
| 555 | Obstructive Sleep Apnea Due to HIV-Associated Lipodystrophy | 5.4 | 15 | Citations (PDF) |
| 556 | Circulating Vascular Progenitor Cells Do Not Contribute to Compensatory Lung Growth | 12.6 | 81 | Citations (PDF) |
| 557 | Parenteral Nutrition with Fish Oil Modulates Cytokine Response in Patients with Sepsis | 12.2 | 222 | Citations (PDF) |
| 558 | Monocytes Are Potent Facilitators of Alveolar Neutrophil Emigration During Lung Inflammation: Role of the CCL2-CCR2 Axis | 0.6 | 194 | Citations (PDF) |
| 559 | Short-Time Infusion of Fish Oil-Based Lipid Emulsions, Approved for Parenteral Nutrition, Reduces Monocyte Proinflammatory Cytokine Generation and Adhesive Interaction with Endothelium in Humans | 0.6 | 176 | Citations (PDF) |
| 560 | Downregulation of hypoxic vasoconstriction by chronic hypoxia in rabbits: effects of nitric oxide | 3.8 | 34 | Citations (PDF) |
| 561 | Sildenafil for Long-Term Treatment of Nonoperable Chronic Thromboembolic Pulmonary Hypertension | 12.2 | 271 | Citations (PDF) |
| 562 | Effects of Mitochondrial Inhibitors and Uncouplers on Hypoxic Vasoconstriction in Rabbit Lungs | 4.3 | 51 | Citations (PDF) |
| 563 | Prevention of Bleomycin-induced Lung Fibrosis by Aerosolization of Heparin or Urokinase in Rabbits | 12.2 | 171 | Citations (PDF) |
| 564 | Selective Inhibition of Large-to-Small Surfactant Aggregate Conversion by Serine Protease Inhibitors of the bis-Benzamidine Type | 4.3 | 8 | Citations (PDF) |
| 565 | Changes in biochemical and biophysical surfactant properties with cardiopulmonary bypass in children | 0.7 | 25 | Citations (PDF) |
| 566 | Leukotriene-mediated coronary vasoconstriction and loss of myocardial contractility evoked by low doses of Escherichia coli hemolysin in perfused rat hearts* | 0.7 | 19 | Citations (PDF) |
| 567 | Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion | 1.1 | 7 | Citations (PDF) |
| 568 | Chemical crosslinking of urokinase to pulmonary surfactant protein B for targeting alveolar fibrin | 4.2 | 17 | Citations (PDF) |
| 569 | Increased neutrophil mediator release in patients with pulmonary hypertension – suppression by inhaled iloprost | 4.2 | 48 | Citations (PDF) |
| 570 | Fibrinolysis-inhibitory capacity of clot-embedded surfactant is enhanced by SP-B and SP-C | 3.4 | 5 | Citations (PDF) |
| 571 | Interaction of Antibodies to Proteinase 3 (Classic Anti-Neutrophil Cytoplasmic Antibody) with Human Renal Tubular Epithelial Cells: Impact on Signaling Events and Inflammatory Mediator Generation | 0.6 | 12 | Citations (PDF) |
| 572 | Pharmacokinetics and Metabolism of Infused versus Inhaled Iloprost in Isolated Rabbit Lungs | 3.1 | 23 | Citations (PDF) |
| 573 | Serum Levels of Vascular Endothelial Growth Factor Are Elevated in Patients with Obstructive Sleep Apnea and Severe Nighttime Hypoxia | 12.2 | 216 | Citations (PDF) |
| 574 | Apical, But Not Basolateral, Endotoxin Preincubation Protects Alveolar Epithelial Cells Against Hydrogen Peroxide-Induced Loss of Barrier Function: The Role of Nitric Oxide Synthesis | 0.6 | 16 | Citations (PDF) |
| 575 | Inhaled Iloprost for Severe Pulmonary Hypertension | 44.0 | 1,710 | Citations (PDF) |
| 576 | Simvastatin Inhibits Inflammatory Properties ofStaphylococcus aureusα-Toxin | 25.3 | 153 | Citations (PDF) |
| 577 | Molecular Pathways of Monocyte Emigration into the Alveolar Air Space of Intact Mice | 12.2 | 47 | Citations (PDF) |
| 578 | The Role of CC Chemokine Receptor 2 in Alveolar Monocyte and Neutrophil Immigration in Intact Mice | 12.2 | 186 | Citations (PDF) |
| 579 | An ELISA Technique for Quantification of Surfactant Apoprotein (SP)-C in Bronchoalveolar Lavage Fluid | 12.2 | 52 | Citations (PDF) |
| 580 | A double‐blind, randomized, placebo‐controlled trial of n‐3 versus n‐6 fatty acid‐based lipid infusion in atopic dermatitis | 3.4 | 67 | Citations (PDF) |
| 581 | Adrenomedullin Reduces Endothelial Hyperpermeability | 12.6 | 184 | Citations (PDF) |
| 582 | Hypoxic pulmonary artery fibroblasts trigger proliferation of vascular smooth muscle cells‐role of hypoxia‐inducible transcription factors | 0.7 | 106 | Citations (PDF) |
| 583 | ω-3 Fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation | 3.8 | 106 | Citations (PDF) |
| 584 | Role of resident alveolar macrophages in leukocyte traffic into the alveolar air space of intact mice | 3.4 | 114 | Citations (PDF) |
| 585 | Combination Therapy with Oral Sildenafil and Inhaled Iloprost for Severe Pulmonary Hypertension | 10.5 | 451 | Citations (PDF) |
| 586 | Staphylococcus Aureus Alpha Toxin Mediates Polymorphonuclear Leukocyte-Induced Vasocontraction and Endothelial Dysfunction | 2.4 | 16 | Citations (PDF) |
| 587 | Amplification of the pulmonary vasodilatory response to inhaled iloprost by subthreshold phosphodiesterase types 3 and 4 inhibition in severe pulmonary hypertension | 0.7 | 71 | Citations (PDF) |
| 588 | Mediator generation and signaling events in alveolar epithelial cells attacked by<i>S. aureus</i>α-toxin | 3.4 | 61 | Citations (PDF) |
| 589 | Distinct pathways of lipopolysaccharide priming of human neutrophil respiratory burst: Role of lipid mediator synthesis and sensitivity to interleukin-10 | 0.7 | 13 | Citations (PDF) |
| 590 | Chemical Coupling of a Monoclonal Antisurfactant Protein-B Antibody to Human Urokinase for Targeting Surfactant-Incorporating Alveolar Fibrin | 3.8 | 9 | Citations (PDF) |
| 591 | cDNA Array Hybridization after Laser-Assisted Microdissection from Nonneoplastic Tissue | 3.5 | 76 | Citations (PDF) |
| 592 | Genomic Organization and Regulation of a Human 7-Helix Transmembrane Receptor Which Is Expressed in Pulmonary Epithelial Cells and Induced in Hypoxia | 2.1 | 15 | Citations (PDF) |
| 593 | Aerosolized Vasodilators in Pulmonary Hypertension | 0.0 | 19 | Citations (PDF) |
| 594 | Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial | 52.0 | 748 | Citations (PDF) |
| 595 | Staphylococcal α-toxin provokes neutrophil-dependent cardiac dysfunction: role of ICAM-1 and cys-leukotrienes | 3.8 | 6 | Citations (PDF) |
| 596 | Obstructive Sleep Apnoea Secondary to Superior Vena Cava Thrombosis in a Patient with Activated Protein C Resistance. Obstruktive Schlaf-Apnoe infolge einer Thrombose der oberen Hohlvene bei einem Patienten mit Resistenz gegenuber aktiviertem Protein C | 0.4 | 1 | Citations (PDF) |
| 597 | Cell-Specific Nitric Oxide Synthase-Isoenzyme Expression and Regulation in Response to Endotoxin in Intact Rat Lungs | 3.3 | 74 | Citations (PDF) |
| 598 | In vitro mimicry of essential fatty acid deficiency in human endothelial cells by TNFα impact of ω-3 versus ω-6 fatty acids | 3.7 | 44 | Citations (PDF) |
| 599 | Atrial natriuretic peptide in severe primary and nonprimary pulmonary hypertension | 2.4 | 58 | Citations (PDF) |
| 600 | Comparison of Different Detection Methods in Quantitative Microdensitometry | 3.5 | 34 | Citations (PDF) |
| 601 | Title is missing! | 4.5 | 216 | Citations (PDF) |
| 602 | NO and reactive oxygen species are involved in biphasic hypoxic vasoconstriction of isolated rabbit lungs | 3.4 | 60 | Citations (PDF) |
| 603 | Conebulization of surfactant and urokinase restores gas exchange in perfused lungs with alveolar fibrin formation | 3.4 | 18 | Citations (PDF) |
| 604 | Monocytes recruited into the alveolar air space of mice show a monocytic phenotype but upregulate CD14 | 3.4 | 121 | Citations (PDF) |
| 605 | Alveolar epithelial barrier functions in ventilated perfused rabbit lungs | 3.4 | 23 | Citations (PDF) |
| 606 | Combination of nonspecific PDE inhibitors with inhaled prostacyclin in experimental pulmonary hypertension | 3.4 | 37 | Citations (PDF) |
| 607 | PROTECTION AGAINST GAS EXCHANGE ABNORMALITIES BY PRE-AEROSOLIZED PGE 1, ILOPROST AND NITROPRUSSIDE IN LUNG ISCHEMIA-REPERFUSION1 | 1.1 | 38 | Citations (PDF) |
| 608 | Pulmonary surfactant: functions, abnormalities and therapeutic options | 11.7 | 147 | Citations (PDF) |
| 609 | Cellular pathophysiology and therapy of pulmonary hypertension | 2.4 | 57 | Citations (PDF) |
| 610 | Physiologic basis for the treatment of pulmonary hypertension | 2.4 | 82 | Citations (PDF) |
| 611 | Biosynthesis of constitutive nitric oxide synthase-derived nitric oxide attenuates coronary vasoconstriction and myocardial depression in a model of septic heart failure induced by Staphylococcus aureus α-toxin | 0.7 | 30 | Citations (PDF) |
| 612 | Human Endothelial Cell Activation and Mediator Release in Response to Listeria monocytogenesVirulence Factors | 2.7 | 70 | Citations (PDF) |
| 613 | Cell Density Regulates Neutrophil IL-8 Synthesis: Role of IL-1 Receptor Antagonist and Soluble TNF Receptors | 0.6 | 31 | Citations (PDF) |
| 614 | Pathophysiology of Acute Lung Injury | 2.4 | 35 | Citations (PDF) |
| 615 | Coaerosolization of Phosphodiesterase Inhibitors Markedly Enhances the Pulmonary Vasodilatory Response to Inhaled Iloprost in Experimental Pulmonary Hypertension | 12.2 | 57 | Citations (PDF) |
| 616 | Urodilatin, a Natriuretic Peptide Stimulating Particulate Guanylate Cyclase, and the Phosphodiesterase 5 Inhibitor Dipyridamole Attenuate Experimental Pulmonary Hypertension | 4.3 | 23 | Citations (PDF) |
| 617 | Alveolar JE/MCP-1 and Endotoxin Synergize to Provoke Lung Cytokine Upregulation, Sequential Neutrophil and Monocyte Influx, and Vascular Leakage in Mice | 12.2 | 74 | Citations (PDF) |
| 618 | Endogenous Nitric Oxide Synthesis and Vascular Leakage in Ischemic-Reperfused Rabbit Lungs | 12.2 | 18 | Citations (PDF) |
| 619 | Alteration of Fatty Acid Profiles in Different Pulmonary Surfactant Phospholipids in Acute Respiratory Distress Syndrome and Severe Pneumonia | 12.2 | 144 | Citations (PDF) |
| 620 | SHORT-TERM ???PRECONDITIONING??? WITH INHALED NITRIC OXIDE PROTECTS RABBIT LUNGS AGAINST ISCHEMIA-REPERFUSION INJURY1 | 1.1 | 34 | Citations (PDF) |
| 621 | Inhaled Iloprost To Treat Severe Pulmonary Hypertension: An Uncontrolled Trial | 10.5 | 235 | Citations (PDF) |
| 622 | Immunostaining and Laser-Assisted Cell Picking for mRNA Analysis | 3.3 | 58 | Citations (PDF) |
| 623 | The PDE inhibitor zaprinast enhances NO-mediated protection against vascular leakage in reperfused lungs | 3.4 | 13 | Citations (PDF) |
| 624 | Phenotypic characterization of alveolar monocyte recruitment in acute respiratory distress syndrome | 3.4 | 183 | Citations (PDF) |
| 625 | Hypoxic vasoconstriction in intact lungs: a role for NADPH oxidase-derived H<sub>2</sub>O<sub>2</sub>? | 3.4 | 89 | Citations (PDF) |
| 626 | PAF-induced synthesis of tetraenoic and pentaenoic leukotrienes in the isolated rabbit lung | 3.4 | 18 | Citations (PDF) |
| 627 | The Effect of Repeated Ozone Exposures on Inflammatory Markers in Bronchoalveolar Lavage Fluid and Mucosal Biopsies | 12.2 | 127 | Citations (PDF) |
| 628 | Nitric Oxide (NO)–Dependent but Not NO-Independent Guanylate Cyclase Activation Attenuates Hypoxic Vasoconstriction in Rabbit Lungs | 4.3 | 24 | Citations (PDF) |
| 629 | Differential Impact of Ultrasonically Nebulized Versus Tracheal-instilled Surfactant on Ventilation-Perfusion (V˙<scp>A</scp>/Q˙) Mismatch in a Model of Acute Lung Injury | 12.2 | 30 | Citations (PDF) |
| 630 | Alveolar Fibrin Formation Caused by Enhanced Procoagulant and Depressed Fibrinolytic Capacities in Severe Pneumonia | 12.2 | 337 | Citations (PDF) |
| 631 | Synthesis of Arachidonic Acid–Derived Lipoxygenase and Cytochrome P450 Products in the Intact Human Lung Vasculature | 12.2 | 44 | Citations (PDF) |
| 632 | Enhanced Release of Superoxide from Polymorphonuclear Neutrophils in Obstructive Sleep Apnea | 12.2 | 595 | Citations (PDF) |
| 633 | Monocyte Migration Through the Alveolar Epithelial Barrier: Adhesion Molecule Mechanisms and Impact of Chemokines | 0.6 | 122 | Citations (PDF) |
| 634 | Immunostaining for Cell Picking and Real-Time mRNA Quantitation | 3.5 | 51 | Citations (PDF) |
| 635 | Rat Pulmonary Cyclooxygenase-2 Expression in Response to Endotoxin Challenge | 3.5 | 40 | Citations (PDF) |
| 636 | A comparison of the acute hemodynamic effects of inhaled nitric oxide and aerosolized iloprost in primary pulmonary hypertension | 2.4 | 305 | Citations (PDF) |
| 637 | Evidence for a role of protein kinase C in hypoxic pulmonary vasoconstriction | 3.4 | 44 | Citations (PDF) |
| 638 | Cleavage of Surfactant-Incorporating Fibrin by Different Fibrinolytic Agents | 4.3 | 14 | Citations (PDF) |
| 639 | Role of Actin Depolymerization in the Surfactant Secretory Response of Alveolar Epithelial Type II Cells | 12.2 | 43 | Citations (PDF) |
| 640 | Low-dose Systemic Phosphodiesterase Inhibitors Amplify the Pulmonary Vasodilatory Response to Inhaled Prostacyclin in Experimental Pulmonary Hypertension | 12.2 | 75 | Citations (PDF) |
| 641 | Prostacyclin Enhances Stretch-induced Surfactant Secretion in Alveolar Epithelial Type II Cells | 12.2 | 38 | Citations (PDF) |
| 642 | Surfactant Subtype Conversion Is Related to Loss of Surfactant Apoprotein B and Surface Activity in Large Surfactant Aggregates | 12.2 | 52 | Citations (PDF) |
| 643 | Severe Microcirculatory Abnormalities Elicited by<i>E. coli</i> Hemolysin in the Rabbit Ileum Mucosa | 12.2 | 21 | Citations (PDF) |
| 644 | Ventilation–Perfusion Mismatch after Lung Ischemia–Reperfusion | 12.2 | 34 | Citations (PDF) |
| 645 | Inhaled Prostacyclin and Iloprost in Severe Pulmonary Hypertension Secondary to Lung Fibrosis | 12.2 | 387 | Citations (PDF) |
| 646 | Role of<i>Listeria monocytogenes</i>Exotoxins Listeriolysin and Phosphatidylinositol-Specific Phospholipase C in Activation of Human Neutrophils | 2.7 | 58 | Citations (PDF) |
| 647 | Effects of arachidonic acid metabolism on hypoxic vasoconstriction in rabbit lungs | 4.4 | 16 | Citations (PDF) |
| 648 | Simultaneous Analysis of 4- and 5-Series Lipoxygenase and Cytochrome P450 Products from Different Biological Sources by Reversed-Phase High-Performance Liquid Chromatographic Technique | 2.4 | 34 | Citations (PDF) |
| 649 | ω-3 Fatty acid–based lipid infusion in patients with chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, multicenter trial | 1.9 | 137 | Citations (PDF) |
| 650 | Nitric Oxide Biosynthesis in an Exotoxin-induced Septic Lung Model | 12.2 | 16 | Citations (PDF) |
| 651 | Abnormalities of Gastric Mucosal Oxygenation in Septic Shock | 12.2 | 159 | Citations (PDF) |
| 652 | Vascular Distension and Continued Ventilation Are Protective in Lung Ischemia/Reperfusion | 12.2 | 30 | Citations (PDF) |
| 653 | Wegener's Granulomatosis: Anti–proteinase 3 Antibodies Are Potent Inductors of Human Endothelial Cell Signaling and Leakage Response | 8.0 | 64 | Citations (PDF) |
| 654 | Use of fish oil to prevent graft rejection | 0.7 | 8 | Citations (PDF) |
| 655 | Nitro blue tetrazolium inhibits but does not mimic hypoxic vasoconstriction in isolated rabbit lungs | 3.4 | 24 | Citations (PDF) |
| 656 | Title is missing! | 3.2 | 29 | Citations (PDF) |
| 657 | Synergism Between Endotoxin Priming and Exotoxin Challenge in Provoking Severe Vascular Leakage in Rabbit Lungs | 12.2 | 10 | Citations (PDF) |
| 658 | Endotoxin priming of thromboxane-related vasoconstrictor responses in perfused rabbit lungs | 3.2 | 14 | Citations (PDF) |
| 659 | Effect of 3 hours of passive smoke exposure in the evening on inflammatory markers in bronchoalveolar and nasal lavage fluid in subjects with mild asthma | 2.2 | 13 | Citations (PDF) |
| 660 | Transfusion-related acute lung injury due to HLA-A2-specific antibodies in recipient and NB1-specific antibodies in donor blood | 2.4 | 182 | Citations (PDF) |
| 661 | Hypoxic vasoconstriction in buffer-perfused rabbit lungs | 1.1 | 75 | Citations (PDF) |
| 662 | Hydrogen Peroxide-Induced Increase in Lung Endothelial and Epithelial Permeability-Effect of Adenylate Cyclase Stimulation and Phosphodiesterase Inhibition | 2.6 | 58 | Citations (PDF) |
| 663 | Proteinaceous bacterial toxins and pathogenesis of sepsis syndrome and septic shock: the unknown connection | 3.0 | 25 | Citations (PDF) |
| 664 | Computer-assisted morphometry of the intracapillary leukocyte pool in the rabbit lung | 2.7 | 22 | Citations (PDF) |
| 665 | Proteolytic Cleavage of Fibrinogen: Amplification of Its Surfactant Inhibitory Capacity | 4.3 | 28 | Citations (PDF) |
| 666 | Endotoxin Primes Perfused Rabbit Lungs for Enhanced Vasoconstrictor Response to Staphylococcal α-Toxin | 3.4 | 21 | Citations (PDF) |
| 667 | Lung Surfactant Phospholipids Associate with Polymerizing Fibrin: Loss of Surface Activity | 4.3 | 84 | Citations (PDF) |
| 668 | Type II Alveolar Epithelial Eicosanoid Metabolism: Predominance of Cyclooxygenase Pathways and Transcellular Lipoxygenase Metabolism in Co-culture with Neutrophils | 4.3 | 37 | Citations (PDF) |
| 669 | Surface properties and sensitivity to protein-inhibition of a recombinant apoprotein C-based phospholipid mixture in vitro — comparison to natural surfactant | 2.6 | 31 | Citations (PDF) |
| 670 | Procoagulant activity in bronchoalveolar lavage of severely traumatized patients-relation to the development of acute respiratory distress | 2.4 | 31 | Citations (PDF) |
| 671 | Lung Vascular Injury after Administration of Viable Hemolysin-forming<i>Escherichia coli</i>in Isolated Rabbit Lungs | 3.4 | 33 | Citations (PDF) |
| 672 | Local Complement Activation, Thromboxane-mediated Vasoconstriction, and Vascular Leakage in Isolated Lungs: Role of the Terminal Complement Sequence | 3.4 | 33 | Citations (PDF) |
| 673 | Surfactant Abnormalities in Patients with Respiratory Failure after Multiple Trauma | 3.4 | 226 | Citations (PDF) |
| 674 | Effects of alpha-tocopherol, its carboxylic acid chromane compound and two novel antioxidant isoflavanones on prostaglandin H synthase activity and autodeactivation | 2.7 | 4 | Citations (PDF) |
| 675 | A Highly Sensitive Gas Chromatographic Method Does not Detect Exhalation of Volatile Hydrocarbons from Isolated Ventilated Lungs under Massive Peroxidative Stress | 1.7 | 8 | Citations (PDF) |
| 676 | Role of Membrane Lipids in the Pulmonary Vascular Abnormalities Caused by Bacterial Toxins | 3.4 | 33 | Citations (PDF) |
| 677 | Arachidonic Acid Lipoxygenase Pathways and Increased Vascular Permeability in Isolated Rabbit Lungs | 3.4 | 55 | Citations (PDF) |
| 678 | Septic Lung | 5.4 | 25 | Citations (PDF) |
| 679 | Release of leukotrienes into the perfusate of calcium-ionophore stimulated rabbit lungs | 5.2 | 55 | Citations (PDF) |
| 680 | Pseudomonas aeruginosa cytotoxin stimulates prostacyclin production in cultured pulmonary artery endothelial cells: Membrane attack and calcium influx | 4.2 | 79 | Citations (PDF) |
| 681 | Alteration of alveolar surfactant function after exposure to oxidative stress and to oxygenated and native arachidonic acid in vitro | 2.6 | 59 | Citations (PDF) |
